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palavras-chave 
 
Separação enantiomérica, sistemas aquosos bifásicos, excesso 
enantiomérico, ácido mandélico, líquidos iónicos, líquidos iónicos 
quirais, sistemas de duas fases sólida-líquida 
Resumo 
 
 
Tipicamente, apenas um dos enantiómeros é responsável 
pelo efeito pretendido de um fármaco, sendo que o outro pode 
levar a respostas menos potentes ou até mesmo indesejadas. As 
entidades reguladoras praticam políticas restritas em relação à 
comercialização de fármacos como misturas racémicas. Assim, a 
indústria farmacêutica tem enfrentado desafios relacionados com 
o desenvolvimento de métodos para produção de fármacos 
oticamente puros. No entanto, e considerando a dificuldade 
acrescida na produção de enantiómeros puros por síntese direta, 
a síntese de misturas racémicas seguida da sua purificação surge 
como uma alternativa mais barata, simples e flexível.  
Os sistemas aquosos bifásicos (SABs) e os sistemas de 
duas fases sólida-líquida (SDFSL) são técnicas alternativas mais 
biocompatíveis que têm sido utilizados como técnicas de 
separação enantiosseletiva de fármacos e/ou aminoácidos com 
enantiosseletividades bastante promissoras. Para além disso, 
apresentam benefícios de custo, rapidez, simplicidade e 
versatilidade de operação e possibilidade de aumento de escala.  
Este trabalho foca-se no desenvolvimento de SABs e 
SDFSL constituídos por seletores quirais que possam atuar 
simultaneamente como solvente. Numa primeira abordagem o 
objetivo foi desenvolver novos SABs quirais, mais biocompatíveis, 
simples e eficientes. Para tal, SABs constituídos por açúcares, 
aminoácidos e líquidos iónicos quirais foram aplicados na 
resolução enantiomérica de ácido mandélico racémico. O sistema 
mais promissor, composto por [C1Qui][C1SO4] + K3PO4, obteve um 
excesso enantiomérico de -33.4%. Numa segunda abordagem, foi 
possível criar uma alternativa mais simples e mais eficiente 
recorrendo a SDFSL. Com estes sistemas, foi obtido o valor mais 
elevado de excesso enantiomérico deste trabalho, de 49.0%, 
através da precipitação enantiosseletiva do R-ácido mandélico por 
interação com [N4444][D-Phe]. 
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Abstract 
 
Conventionally, only one of the enantiomers is responsible 
for the intended effect of a drug, whilst the other may lead to a less 
potent or even undesired response. Regulation entities are very 
strict regarding the commercialization of racemic drugs. Thus, 
pharmaceutical industry has been facing challenges related to the 
creation of methods to produce optically active drugs. However, 
considering the increased difficulty in the production of pure 
enantiomers by direct synthesis, the synthesis of racemic mixtures 
followed by their purification appears as a cheaper, simpler and 
more flexible alternative.  
Aqueous biphasic systems (ABS) and solid-liquid biphasic 
system (SLBS) are more biocompatible alternatives that have been 
used to separate racemic drugs and amino acids with promising 
enantioselectivities. Furthermore, these are cost-effective, quick, 
simple and operationally flexible. 
This work intended to develop ABS and SLBS using chiral 
selectors that can simultaneously act as solvents. In a first attempt, 
chiral ABS of better biocompatibility, simplicity and efficiency were 
developed. For that purpose, ABS constituted by sugars, amino 
acids and chiral ionic liquids (CILs) were applied for chiral 
resolution of racemic mandelic acid (MA). The most promising ABS 
was a system composed of [C1Qui][C1SO4]  + K3PO4 which yielded 
the maximum  enantiomeric excess of -33.4%. In a second 
approach, it was possible to create a simpler and more efficient 
technique resorting to SLBS. The enantiomeric excess value of 
49.0% was achieved, by the enantioselective precipitation of the R-
MA caused by interactions with [N4444][D-Phe]. 
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1. General Introduction 
Like the two hands of a person, a molecule is chiral if not superimposable to its 
mirror image (Figure 1). Enantiomers share the same physical and chemical properties, 
with the exception that they rotate the plane of polarized light in opposite directions to 
the same degree.[1] However, biological systems can discriminate between the two 
enantiomers of a molecule, having different physiological responses. In the case of a drug, 
it is common that only one of the isomers exerts the desired therapeutic effect. For most 
racemic drugs, the pharmaceutical activity is essentially inherent to one of the 
enantiomers (the eutomer), while the other is often inert, nefarious or responsible for 
unpredictable and undesired side effects (the distomer).[2,3] 
 
Figure 1. Generic representation of a chiral structure with two non-superimposable forms (■≠▲≠●≠♦) as 
an analogy to two hands. Adapted from [1]. 
 
In 1886, Piutti reported one of the first cases associated with the distinct biological 
effects of enantiomers, in particular the taste of asparagine enantiomers. The L-isomer is 
tasteless, while the D-isomer has a sweet taste.[4] Almost a century later, in the late 1950s 
and early 1960s, the “thalidomide scandal” occurred. Thalidomide was available as a 
racemic mixture in the market, where the (R)-isomer exhibits the desired effects and the 
(S)-isomer is teratogenic and induces birth defects. Since thalidomide was widely 
prescribed to heal nausea in pregnant women, over 10,000 embryos were affected.[2,5] 
Several chiral drugs have been investigated ever since, as indicated in some reviews.[6,7] 
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Under this scenario, attention was drawn to the stereochemistry of drugs and the 
regulation entities around the world[8,9] are nowadays stricter. In the beginning of the 
2000’s, more than 70% of new chiral drugs were commercialized in their enantiopure 
form,[2] due to the more selective pharmacodynamics profile, the reduction in complex 
drug interactions and patients exposure to weaker doses of the drug. However, selling a 
drug in its racemic form forces the pharmaceutical companies to provide detailed 
toxicological and pharmacological data for each enantiomer and the respective racemate.  
In this context, it is necessary to find new methods to produce enantiopure drugs. 
There are two main approaches aimed at obtaining enantiopure compounds (Figure 2): 
the asymmetric synthesis and the separation of racemates.[2] Asymmetric synthesis, which 
was object of a Noble Prize in 2001,[10] comprises both non-enzymatic and enzymatic 
methods. It is the most powerful approach to obtain enantiopure compounds. 
Nevertheless, asymmetric synthesis generally requires highly enantiopure raw materials 
and or highly stereospecific catalysts that make it expensive and limited by the number 
of reactions needed to obtain highly enantiopure compounds. The separation of 
enantiomers from a racemate consists of a simpler, more flexible and cheaper alternative 
to asymmetric synthesis. 
 
Figure 2. Most common methods for producing enantiopure compounds (dashed lines) and alternative 
methods resorting to chiral aqueous biphasic systems and solid-liquid biphasic systems (full lines). 
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Racemic synthesis followed by enantiomer separation is a propitious strategy for 
the production of enantiopure compounds. In general, the time-to-market for this 
approach is significantly shorter than for asymmetric catalysis.[11] The separation of pure 
enantiomers from a racemic mixture can be performed by several techniques, with 
chromatography and crystallization being the most common, as summarized in Figure 2.  
Crystallization has on its basis the formation of diastereomeric salts or 
conglomerates of distinct solubilities. On the other hand, chromatography lies on the 
formation of diastereomers by derivatization (indirect) or diastereomeric complexes with 
a chiral selector (direct) allowing the enantiomers separation in a chromatographic 
column.[12,13] Overall, crystallization has operational simplicity, cost efficiency and can 
be easily coupled to other techniques. As an example, Köllges et al. proposed and 
optimized a continuous crystallization process resorting to a mill to separate 
conglomerate forming enantiomers achieving a 100% purity yield.[14] However, only 5 to 
10% of the racemic mixtures form conglomerates, being thus limited to a certain number 
of chiral compounds. Moreover, it normally requires an additional step of enantiomeric 
enrichment to overcome the low yields obtained.[13,15]  
In turn, chromatographic techniques are quick and applicable to a large number of 
racemates. Moreover, they are flexible due to the number of chiral stationary phases and 
chiral columns currently available and the racemates that they can resolve.[16] For 
instance, Wang et al. evaluated the enantioseparation for several compounds through 
HPLC using newly synthesized chiral stationary phases.[17] With a maximum separation 
factor of 5.83, they have proved the great potential of the novel stationary phases. 
However, chromatography has its industrial application limited by the high costs 
associated with the enantioselective columns and the low loading capacities.[18] 
Enantioselective liquid-liquid extraction (ELLE) is cost-effective, quick, simple 
and versatile to operate and easy to scale up.[11] Aqueous biphasic systems (ABS), a 
particular type of LLE, add extra degrees of versatility and biocompatibility to 
conventional ELLE.[19] Although its application to resolve racemates remains scarcely 
studied, ABS are promising routes for chiral resolution. Enantiomeric precipitation shows 
to be another route of enhanced simple execution and reasonably low cost, if compared 
to ABS. By using solid-liquid biphasic systems (SLBS) with tunable solvents, the 
applicability of classic crystallization/precipitation techniques can be extended. 
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1.1. Scopes and objectives 
In this work, the main focus is to develop robust and simple enantioseparation 
platforms based on ELLE, in particular chiral ABS, and on SLBS (Figure 3). Thus, the 
core objective of this thesis is to extend and investigate the applicability of chiral ABS 
and SLBS to separate racemic compounds as efficient and biocompatible alternatives to 
the most common techniques.  
It is intended to develop enantioselective ABS in which the chiral selector is 
simultaneously one of the phase-forming components, thus creating a highly performant, 
yet of simple implementation, separation platform. 
Given the promising status of ionic liquids (ILs) when applied in ABS,[19] mainly 
due to their “designer solvent” character, this thesis aims at enlarging the range of ABS 
based on ILs for chiral resolution purposes. By enantiomers’ partition studies for each 
ABS class, their chiral resolution will be evaluated. This will allow the proper selection 
of the phase formers yielding the most promising enantioseparations. Thus, a complete 
screening of different ABS will be done covering three classes: 
i) IL/carbohydrate-based ABS; 
ii) IL/amino acid-based ABS 
iii) CIL/salt-based ABS (where chirality can be present on the IL cation, anion or 
both). 
The IL role in these ABS is that of only a solvent (class i and ii, where the chiral 
selectors are carbohydrates and amino acids) and simultaneously of solvent and chiral 
selector (class iii). 
Considering the useful role of ILs in the precipitation or crystallization of several 
compounds,[20–22] including drugs,[23,24] SLBS composed of chiral ILs (CILs) aqueous 
solutions will be developed. This technique is used to promote the enantioselective 
precipitation of only one enantiomer in a racemic mixture due to cooperative interactions 
with the CILs. When compared to ABS, this class of systems is of simpler nature since it 
allows the isolation of the target enantiomer in a single step.  
Mandelic acid (MA) was selected as the model racemic compound to perform this 
work due to its wide industrial application. In cosmetics, MA is used in several skin care 
products due to its antibacterial and facial skin renovating activities.[25,26] The interest on 
resolving MA racemates is to obtain R-MA, which is an intermediate used as a precursor 
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for semisynthetic penicillin and cephalosporin and many other pharmaceuticals, and a 
good resolving agent.[27]. 
 
 
Figure 3. Thesis overview. 
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2. Separation of enantiomers using ELLE 
2.1. Literature review 
As mentioned above, the scalability, reduced costs and easy operation of ELLE 
makes it an attractive alternative for enantiomers separation when compared to the most 
common techniques. ELLE requires two immiscible phases, normally an aqueous and an 
organic phase. By combining solvent extraction with chiral recognition, ELLE needs one 
chiral selector (or more), otherwise enantiomeric separation does not take place. The 
introduction of a chiral selector and its partition between the two phases of an ELLE 
system controls the partition of the enantiomers. The chiral recognition is commonly 
monophasic, with the addition of only one chiral selector (Figure 4A). The chiral selectors 
most frequently used are crown ether-based,[28,29] metal complexes and metalloids,[30–32] 
cyclodextrin derivatives [33,34] and tartaric acid-based chiral selectors.[35] Biphasic 
recognition, where two chiral selectors with opposite partition tendencies are introduced 
in the ELLE system, has been proposed to overcome limitations related with the poor 
enantioselectivities achieved (Figure 4B). Cyclodextrin derivatives, highly soluble in the 
aqueous phase, and tartaric acid derivatives, exhibiting high affinity towards the organic 
phase, are the most popular pair of chiral selectors.[36–39] The principle of enantiomeric 
recognition for enantioselective complexation follows the three-point attachment (TPA) 
model – Figure 4C,[40] by which three simultaneous intermolecular interactions, like ion 
pairing, hydrogen bonding, π-π interactions, dipole-dipole and van der Waals, between 
the chiral-host and the chiral-guest take place, as shown in Figure 4C. In addition to the 
advantages already indicated, the enantiomeric excesses attained are very promising.[28–
34,36–39] For instance, it is possible to achieve up to 99% of enantiomeric excess for chiral 
amino acids using a LLE system formed by water/dichloromethane + lipophilic salen-
cobalt(III) complex as the chiral selector.[32] Nevertheless, ELLE uses large amounts of 
volatile organic solvents[41] and often requires additional steps to recover the resolved 
enantiomer. Owing to environmental issues related with the use of these organic solvents, 
that ignore the principles of Green Chemistry,[42] there is an intense search for more 
biocompatible techniques.[11–13] 
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Figure 4. Schematic representation of enantiomeric recognition using LLE systems and the molecular-level mechanisms justifying it: A) recognition with one chiral 
selector; B) recognition with two chiral selectors; C) TPA model.
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2.1.1. Chiral Aqueous Biphasic Systems 
ABS are a specific type of LLE system that do not use toxic or volatile organic 
solvents. They are based on two water-rich phases, which form by mixing two 
incompatible water-soluble solutes above certain concentrations. One of the aqueous 
phases is enriched in one of the solutes, while the coexisting phase is mainly formed by 
the remaining one.[43] Although pairs of two polymers and of a polymer and a salt are the 
most used, multiple combinations appeared in the last decades.[19] Some examples involve 
the use of polar organic solvents,[44,45] surfactants, carbohydrates,[46] amino acids[47] and 
ILs.[19] ABS retain the benefits of traditional LLE (cost-effectiveness, quickness, simple 
operation, easy scale-up and recyclability) while adding the advantages of 
biocompatibility and tunability.[19,48,49] From the extraction of small compounds 
(alkaloids,[50] phenolic compounds[51] and amino acids[52]) and more sensitive 
biomolecules (proteins,[53,54] antibodies[55,56] and nucleic acids[57]) from natural matrices, 
to drugs from pharmaceutical wastes or wastewaters,[58,59] ABS were shown to be highly 
performant and selective if well selected. All the advantages given to ABS bring new 
opportunities considering the development of new/adapted enantioseparation techniques. 
It is in this context that this section is presented. It focuses on two aspects, the first being 
the description of the liquid-liquid equilibria data available for ABS formed by chiral 
compounds as phase formers and the second, the summary of specific cases where the 
chiral resolution of racemates resorting to ABS has been attempted. 
 
2.1.2.1. Liquid-liquid equilibria data for ABS formed by chiral compounds 
Since the extraction/separation of any compound with ABS follows its affinity 
between the two phases, the liquid-liquid equilibria must be described and the impact of 
several operational parameters upon the extraction understood (temperature, pH, mixture 
composition and phases volume ratio). A complete description on how to determine the 
solubility curves, to apply the mathematical descriptions for correlation of the 
experimental data and to fully characterize the phase diagrams was recently reviewed by 
Freire et al.[19] Briefly, the phase diagram allows the definition of the ternary 
compositions able to form the biphasic system and the composition of each individual 
phase (tie-lines, TLs). A schematic representation of a phase diagram is provided in 
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Figure 5. The solubility curve is the boundary between the biphasic (above) and the 
monophasic (below) zones. The TL for a given biphasic mixture composition represents 
the line that links the two nodes that represent the top and bottom phase compositions. 
The difference in the properties of the phases compositions increases with the tie-line 
length (TLL), which is the Euclidean distance between the two nodes. Different mixture 
points chosen along the same TL allow obtaining systems with the same composition at 
the coexisting phases, just differing in the volume ratio of the phases. Finally, the critical 
point represents the biphasic mixture composition with the two aqueous phases 
possessing equal compositions.  
 
Figure 5. Schematic representation of a hypothetic ternary phase diagram fully characterized: solubility 
curve experimental data (), fitting of the experimental data (dashed red line), mixture points and 
corresponding nodes (), TLs (full green line) and critical point (). 
 
Among the huge variety of compounds prone to form ABS, some can present 
chirality, thus being adequate for enantioseparation applications. These can be 
carbohydrates, amino acids, chiral polymers and chiral ILs, combined with other achiral 
compounds (salts, polymers, organic solvents and ILs) – Figure 6. 
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Figure 6. Schematic representation of the pairs of compounds described in literature as phase formers to 
prepare chiral ABS for enantioseparation.[60–66,44,67–80] 
 
2.1.2.1.1. Carbohydrates 
Carbohydrates are chiral molecules that, due its non-charged nature, 
biocompatibility and natural origin have been adopted in the development of greener 
ABS. The use of ABS composed of chiral carbohydrates for the resolution of racemic 
mixtures has been neglected (only two works were described until now, which will be 
further discussed in section 2.1.2.2.[68,72] Still, there is a considerable number of works 
describing the liquid-liquid equilibrium of these systems that is important for the design 
of enantioseparation applications. Carbohydrates were used with polymers[81], organic 
solvents[68,72,82–85] and ILs[46,86,87] to form ABS, as summarized in Table 1. The ability of 
fourteen carbohydrates to form ABS with different water soluble polymers was proposed 
by Sadeghi et al.[81] Polyethylene glycols (PEGs) of different molecular weight were not 
able to form ABS due to their preferential interactions with the carbohydrates. 
Meanwhile, polypropylene glycol (PPG) 400 gmol-1 and PPG 725 gmol-1 (PPG 400 and 
PPG 725), which are more hydrophobic than PEGs, were able to form ABS. From the 
data described in literature, the tendency of the carbohydrates to form ABS with PPG 400 
 12 
 
obeys to the following temperature-independent decreasing order: raffinose > lactose > 
maltitol ≥ maltose > sucrose > galactose > sorbitol > glucose > fructose > arabinose > 
xylitol > mannose > xylose > ribose. Three main tendencies were assessed by the authors: 
i) hexoses (glucose, fructose, galactose and mannose) have better performance than 
pentoses (xylose, ribose and arabinose) forming ABS; ii) trisaccharides (raffinose) are 
stronger than disaccharides (sucrose, maltose and lactose) and monosaccharides forming 
ABS; and iii) polyols (maltitol, sorbitol, xylitol) are stronger than their respective 
saccharides (maltose, glucose, xylose). Due to the high viscosity that polymer-rich phases 
display, other options like polar organic solvents were also evaluated in the ABS 
formation. The four works available studied combinations of saccharides + 
acetonitrile,[83] polyols + acetonitrile,[84] saccharides + tetrahydrofuran[82] and polyols + 
tetrahydrofuran.[85] Cardoso et al. investigated ABS formed by acetonitrile and 
saccharides (D-(+)-glucose, D-(+)-mannose, D-(+)-galactose, D-(+)-xylose, L-(+)-
arabinose, and D-(-)-fructose, sucrose and D-(+)-maltose)[83] and polyols (glycerol, 
erythritol, xylitol, sorbitol and maltitol).[84] The liquid-liquid demixing aptitude decreases 
as follows: D-(+)-galactose > D-(+)-mannose > D-(+)-glucose > D-(+)-xylose > D-(-)-
fructose >L-(+)-arabinose[83] for saccharides and maltitol > sorbitol > xylitol > erythritol 
> glycerol for polyols.[84] Changing the acetonitrile by tetrahydrofuran, slight inversions 
in this behaviour were found,[82] while the polyols kept the same ability to induce phase 
separation.[85] These tendencies, although being slightly distinct in PPG400-based 
ABS,[81] correlate well with the number of carbons and hydration ability of the 
carbohydrates. 
ILs represent another option to overcome the high viscosity of polymeric-based 
ABS. As extensively described in literature, ILs are considered as “designer solvents”, as 
it is possible to pair multiple cations and anions to define and tune their main properties, 
allowing their design as task-specific solvents. Wu and co-authors delivered the first 
report on the combined use of ILs and carbohydrates for ABS formation. Using the IL 1-
butyl-3-methylimidazolium tetrafluoroborate ([C4mim][BF4]) four saccharides were 
screened, being their ability to form ABS described as follows: sucrose > glucose > xylose 
> fructose.[86] After establishing the poor chemical stability of [C4mim][BF4],
[88] Freire et 
al.[46] proposed its replacement by the 1-butyl-3-methylimidazolium 
trifluoromethanesulfonate ([C4mim][CF3SO3]). Moreover, the authors provided a more 
 13 
 
complete screening of carbohydrates.[46] The phase separation ability of the carbohydrates 
studied (Figure 7) followed the trend: D-maltitol > D-(+)-maltose > D-sorbitol > sucrose 
> D-(+)-glucose ≈ D-(+)- galactose > xylitol ≈ D-(-)-fructose ≈ D-(+)-mannose > D-(-)-
arabinose > L-(+)-arabinose > D-(+)-xylose. The trend is, D-(+)-maltose > sucrose > D-
(+)-glucose ≈ D-(+)- galactose > D-(-)-fructose ≈ D-(+)-mannose > D-(-)-arabinose > L-
(+)-arabinose > D-(+)-xylose for saccharides (Figure 7A) and D-maltitol > D-sorbitol > 
xylitol (Figure 7B for polyols) that, with fructose as an exception, agrees with the work 
by Wu et al.[86] In accordance to what was already disclosed for organic solvent-
containing[82–85] and/or PPG400-based systems,[81] four aspects were highlighted: i) the 
number of hydroxyl groups of the sugar, where a higher number of hydroxyl groups will 
favour the ABS formation; ii) hexoses are better to induce the phase split than pentoses; 
iii) the configuration of the hydroxyl groups at the C(2) and C(4) positions demonstrated 
a great influence and iv) polyols are more efficient than the corresponding saccharides in 
the ABS formation.[46] Given the limited number of ILs with adequate properties to form 
ABS with carbohydrates,  Freire and co-workers[87] worked on the synthesis of new 
fluorinated ILs, for which the same tendency towards the ABS formation was 
confirmed.[46] 
Cyclodextrins and their derivatives are oligossacharides widely applied as chiral 
selectors. Recently, Wang and collaborators[68,72] proposed chiral ABS composed of β-
cyclodextrin (β-CD) derivatives for the resolution of racemic phenylsuccinic acid and 
zoplicone. The formation of these systems was performed by their combination with 
organic solvents, namely acetone[68], alcohols[72] and acetonitrile.[72] While the ABS 
formation ability was generally poor for neutral β-CD derivatives – the methyl-β-
cyclodextrin (ME-β-CD) and the hydroxypropyl-β-cyclodextrin (HP-β-CD) – the anionic 
β-CD derivatives – the carboxymethyl-β-cyclodextrin (CM-β-CD) and the sulfobutyl 
ether-β-cyclodextrin (SBE-β-CD) – were much better. This could be attributed to the 
formation of hydration complexes between the water molecules and the anionic β-CD 
derivatives, suppressing the formation of hydration complexes between water and the 
organic solvents.[68,72] Moreover, long chain alcohols and acetonitrile are the organic 
solvents inducing larger biphasic regions, as a result of their higher hydrophobicity.[72]  
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Of importance to highlight is the fact that not all of the carbohydrates overviewed 
in this section are specified as being used in their chiral form. But, as reported by some 
authors, chirality has no major effect on phase formation ability.[46,82] 
 
Figure 7. Phase diagrams of the systems composed of: (A) [C4mim][CF3SO3] + Saccharide + H2O at 298 
K:( )D-(+)-glucose, ( )D-(+)-manose, ( )D-(-)-frutose, ( )D-(+)-galactose, ( )D-(+)-xylose, ( ) 
D-(-)-arabinose, ( )L-(-)-arabinose, ( )D-(+)-maltose, ( )Sucrose; (B) [C4mim][CF3SO3] + Polyol+ 
H2O at 25 (±1)ºC:( )D-Sorbitol, ( )Xylitol, ( )D-maltitol. The insets represent the comparisons 
between (1) monossacharides and (2) dissacharides.  Adapted from [46].  
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Table 2. Summary of carbohydrates applied as chiral phase formers in ABS. 
Carbohydrate Second Phase Component 
Glucose 
[C4mim][CF3SO3]
[46], PPG 400[81], PPG725[81], 
THF[82], acetonitrile [83], [C4mim][BF4]
[86], 
[C2C1py][C4F9SO3]
[87] 
Xylose 
[C4mim][CF3SO3]
[46], PPG 400[81], THF[82], 
acetonitrile [83], [C4mim][BF4]
[86]  
Fructose 
[C4mim][CF3SO3]
[46], PPG 400[81], PPG725[81], 
THF[82], acetonitrile [83], [C4mim][BF4]
[86], 
[C2C1py][C4F9SO3]
[87] 
Arabinose 
[C4mim][CF3SO3]
[46], PPG 400[81], THF[82], 
acetonitrile [83], [C2C1py][C4F9SO3]
[87] 
Mannose 
[C4mim][CF3SO3]
[46], PPG 400[81], THF[82], 
acetonitrile [83], [C2C1py][C4F9SO3]
[87] 
Sucrose 
[C4mim][CF3SO3]
[46], PPG 400[81], PPG725[81], 
THF[82], acetonitrile [83], [C4mim][BF4]
[86], 
[C2C1py][C4F9SO3]
[87] 
Maltose 
[C4mim][CF3SO3]
[46], PPG 400[81], THF[82], 
acetonitrile [83], [C2C1py][C4F9SO3]
[87], 
[C2C1im][C4F9SO3]
[87]  
β-CD derivatives 
Ethanol[72], 1-propanol[72], 2-propanol[72], 
acetonitrile[72], acetone [68] 
Glycerol acetonitrile[84], THF[85] 
Erythritol acetonitrile[84], THF[85] 
Xylitol 
[C4mim][CF3SO3]
[46], PPG 400[81], acetonitrile[84], 
THF[85], [C2C1py][C4F9SO3]
[87] 
Sorbitol 
[C4mim][CF3SO3]
[46], PPG 400[81], acetonitrile[84], 
THF[85], [C2C1py][C4F9SO3]
[87] 
Maltitol 
[C4mim][CF3SO3]
[46], PPG 400[81], acetonitrile[84], 
THF[85], [C2C1py][C4F9SO3]
[87] 
Galactose 
[C4mim][CF3SO3]
[46], PPG 400[81], acetonitrile [83], 
[C2C1py][C4F9SO3]
[87] 
Raffinose PPG 400[81] 
Lactose PPG 400[81] 
Ribose PPG 400[81] 
 
2.1.2.1.2. Amino acids  
Amino acids appear in the ABS domain as phase formers for the same reasons of 
carbohydrates, namely their simple chemical structure and the ready availability of both 
enantiomers.[89] Glycine, as the only achiral amino acid, will be discarded from this 
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literature overview. Polymers,[90] surfactants[91] and ILs,[47,92] can be combined with 
amino acids to form ABS. As reported by Sadeghi et al.,[90] PPG 400 and PPG 725 are 
able to form ABS with amino acids, contrarily to PEG-based polymers as found for 
carbohydrates.[81] Serine (the most efficient for salting-out), alanine and proline (the least 
prone for salting-out) were the amino acids tested, as shown in Figure 8. Moreover, the 
ABS formation is improved by the amino acid hydrophilicity, temperatures and polymers 
molecular weight.  
 
Figure 8. Phase diagrams of the systems composed of PPG400 + Amino acid + H2O at 298 K:( ) Alanine, 
( ) Serine, ( ) Proline. Adpated from [90]. 
 
Due to their amphiphilic nature and improved biocompatibility, surfactants have 
been also used to create ABS.[93–95] Although several surfactants may exhibit chirality,[96–
99] thus serving as chiral selectors in enantioseparation processes, there is no report on 
their use as phase formers in chiral ABS. But, the achiral Triton X-100 + L-proline ABS 
was proposed by Chakraborty and collaborators.[91] No promising status was identified, 
since the system presents a limited window of conditions at which is stable (< 3 mol.kg-1 
of L-proline and 6 < pH < 8), thus requiring a hydrophobic additive. 
ILs are also promising phase former pairs for amino acids, as first proposed by 
Zhang et al.[92] and then by Domínguez-Pérez et al.[47] L-serine and L-proline combined 
with the [C4mim][BF4] were able to form ABS following the same amino acids’ ranking 
of PPGs-based ABS.[92] However, the temperature dependency of amino acids + ILs ABS 
was opposite to that obtained for amino acids + PPGs systems.[90] Again, 
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[C4mim][CF3SO3] and 1-butyl-3-methylimidazolium dicyanamide ([C4mim] 
[N(CN)2])
[47] were proposed as stable replacements to [C4mim][BF4].
[88] Lysine and its 
monohydrochloride form, as well as proline, were the amino acids investigated, with 
lysine presenting higher aptitude to form ABS than proline. The 3 authors justified these 
results by the hydrophilicity of the amino acid that enlarges the biphasic region of the 
phase diagram, as previously described in other works.[90,92] Lysine and Lysine HCl bear 
an additional –NH2 group in its side chain, being thus more soluble in water than proline. 
 
Table 2. Summary of the amino acids applied in the formation of ABS. 
Amino acid Second Phase Component 
Alanine PPG400[90], PPG725[90] 
Serine [C4mim][BF4]
[92], PPG400[90], PPG725[90]  
Proline 
[C4mim][BF4]
[47,92], [C4mim][CF3SO3]
[47], [C4mim][N(CN)2]
[47], 
Triton X-100[91], PPG400[90], PPG725[90] 
Lysine [C4mim][BF4],
[47] [C4mim][CF3SO3],
[47] [C4mim][N(CN)2]
[47] 
 
2.1.2.1.3. Chiral Polymers  
Another interesting approach to develop chiral ABS is to synthesize specific 
polymers with both chiral selector potential and ABS formation capacity. This was 
proposed by Tan and his collaborators [63], who have synthesized a new thermo-sensitive 
polymer, poly(MAH-β-CD-co-NIPAAm), through the copolymerization of N-
isopropylazylamide (NIPAAm) with maleic anhydride (MAH) modified β-CD. The phase 
diagram of poly(MAH-β-CD-co-NIPAAm) + dextran ABS was determined and further 
utilized for chiral separation of mandelic acid (MA) enantiomers (further discussed in 
section 2.1.2.2.). Poly(MAH-β-CD-co-NIPAAm) has chiral selector potential due to the 
formation of a hydrophobic cavity, which hosts the chiral guests. 
 
Table 3. Summary of the polymers applied in the formation of chiral ABS. 
Chiral Polymer Second Phase Component 
Poly(MAH-β-CD-co-NIPAAm) Dextran T40[63] 
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2.1.2.1.4. Chiral Ionic Liquids  
The ILs are a class of salts with low melting temperatures, usually below 100 ºC, 
due to the low symmetry of the composing ions and low charge density that precludes 
their organization into a crystal lattice.[100] Among all the unique properties of ILs 
(negligible vapour pressure at atmospheric conditions, strong solvation ability for a wide 
variety of compounds, high thermal and chemical stability),[19] their already mentioned 
“designer solvent” character[101] stands out if they are to be used as chiral selectors. 
Cations and anions bearing chirality can be used as starting materials to synthesize CILs, 
where the chirality can be defined on the cation, anion or on both.[102] Some examples are 
amino acid ester-based,[103] benzimidazolium-based,[104] amino alcohol-derived,[105] 
nicotine-based[106] and isomannide-based [107] CILs. These are gaining much favour in 
processes where enantioselectivity is mandatory[102,108] and in particular for chiral ABS 
applications.[19] Some works have already applied CILs-based ABS in the resolution of 
racemates, as it will be discussed in section 2.1.2.2.. Wu et al. synthesized two chiral 
functionalized imidazolium-based ILs with the chirality in the cation and sharing the 
hexafluorophosphate anion ([PF6]
-), [ChiralFunct1C1im][PF6] and 
[ChiralFunct2C1im][PF6]. ABS composed of these two hydrophilic CILs and the 
inorganic salt Na2SO4 have been created with the specific goal of resolving racemates of 
amino acids.[76] With no major impact of the CILs’ structure upon the phase formation, 
only very small amounts of Na2SO4 are necessary to reach the biphasic zone. While [PF6]
-
also partially hydrolyses in aqueous medium,[88] Wu et al.[77] provided another group of 
task-specific CILs for the resolution of racemic mixtures of amino acids. Tropine-like ILs 
of increasing alkyl side chain length having the prolinate ([Cntropine][Pro], with 2 ≤ n ≤ 
8) were synthesized and further combined with salts in the formation of ABS. The 
molecular scenario behind the formation of ABS is in good agreement with other IL-
based ABS[19]: i) larger alkyl chains are better for ABS formation due the higher 
hydrophobic character of the [Cntropine][Pro]; ii) the effect of the salt type was studied 
with K3PO4, K2HPO4 and K2CO3, following the Hofmeister series; and iii) the increase 
in temperature, analogously to what was observed for achiral ILs + amino acids,[92] is 
limiting the ABS formation. Several cholinium-based ILs containing either natural amino 
acids or other organic acids as the anion moiety were also applied. Although these have 
appeared to create more biocompatible IL-based ABS, some of the structures available 
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are chiral. So, ABS composed of CILs based on the cholinium anion, [Ch]+, can be 
promising for enantioselective extractions. Several cholinium-amino acid-based ILs are 
available, namely cholinium phenylalaninate ([Ch][Phe]), cholinium leucinate 
([Ch][Leu]), cholinium valinate ([Ch][Val]), cholinium lysinate ([Ch][Lys]), cholinium 
β-alaninate ([Ch][β-Ala]), cholinium serinate ([Ch][Ser]) and cholinium glycinate 
([Ch][Gly]). [Ch][Gly] being achiral will not be considered here. Cholinium-based CILs 
can undergo phase separation with inorganic salts of enhanced salting-out aptitude 
(K3PO4 and K2CO3)
[109] or with polymers (e.g. PPG400).[110] In the salt-based system, 
cholinium-based ILs are salted-out by the inorganic salt, while in the polymer-containing 
system they salt-out the PPG400. Wang et al.[109] observed that, in the presence of K3PO4 
and K2CO3, the ability of the three cholinium-amino acid-based ILs to generate ABS 
follows the hydrogen-bond donation ability of the anions. The highest aptitude of K3PO4 
to salt-out the CIL when compared with the K2CO3 follows the Hofmeister series, as also 
shown for [Cntropine][Pro]-based systems.
[77] Increased temperatures again proved to 
diminish the potential for ABS formation as in other CILs + salts[77] and achiral ILs + 
amino acids[92] systems. PPG400 was used with cholinium-amino acid-based ILs[110] and 
the tendency to induce phase separation is the following (Figure 9): [Lys] > [Ser] ≈ [β-
Ala]. In this work, it is shown that the molecular-level mechanisms that justify these 
results are different from those used in the work of Wang et al.[109] Recently, cholinium-
based ILs having natural organic acids were applied in the formation of ABS of polymeric 
basis.[111] Among the nine ILs synthesized by the authors, four possess chirality due to 
the presence of a chiral anion, namely cholinium abietate ([Ch][Abt]), cholinium L-
ascorbate ([Ch][L-Asc]), cholinium D-galactouronate ([Ch][D-Gal]) and cholinium D-
quinate ([Ch][Qui]). While [Ch][Abt] failed to form ABS with PPG400 due to its higher 
hydrophobicity, the remaining acted according to the trend [Ch][D-Qui] ≃ [Ch][D-Gal] 
> [Ch][Asc]. In agreement with the previous works evaluated, the hydration aptitude of 
each acid dominates the ABS.[110] If more hydrophobic anions are better to form CIL + 
inorganic salts ABS, the opposite occurs in CILs + PPG400 ABS.[110,109,111] 
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Figure 9. Phase diagrams of the systems composed of PPG400+ [Ch][AA] + H2O at 298 K:( )[Ch][Lys], 
( ) [Ch][Ser], ( ) [Ch][Ala]. Adpated from [110]. 
 
Table 4.  Summary of the chiral ionic liquids applied in the formation of chiral ABS. 
Chiral Ionic Liquids Second Phase Component 
[ChiralFunct1C1im][PF6] Na2SO4
[76] 
[ChiralFunct2C1im][PF6] Na2SO4
[76] 
[CnTropine][Pro] K3PO4
[77], K2HPO4
[77], K2CO3
[77] 
[Ch][Phe] K3PO4
[109], K2CO3
[109] 
[Ch][Leu] K3PO4
[109], K2CO3
[109] 
[Ch][Val] K3PO4
[109], K2CO3
[109] 
[Ch][Lys] PPG 400[110] 
[Ch][β-Ala] PPG 400[110] 
[Ch][Ser] PPG 400[110] 
[Ch][D-Qui] PPG 400[111] 
[Ch][L-Asc]  PPG 400[111] 
[Ch][D-Gal] PPG 400[111] 
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Not only the chemical structure of the chiral phase former[63,64] and the 
temperature[60,61,63,64] are important operational parameters when enantioseparation 
applications are focused. Although not previously studied in the context, pH is also 
important as will be discussed in section 2.1.2.2. 
 
2.1.2.2. Application of chiral ABS to enantioselective separation processes 
The application of ABS for enantioseparation processes was first proposed by 
Sellergren and Ekberg in 1985.[78] Figure 10 summarizes the incidence of works based on 
the type of ABS (A), type of racemate (B) and type of chiral selector (C). Few studies 
suggest the use of different chiral molecules (chiral ILs,[76,77] β-CD derivatives[68,72] and 
polymer[63]) simultaneously as phase-forming components and chiral selectors (24%, 
Figure 10A). These systems involve the use of a lower number of chemicals, being thus, 
considered simpler. Still, the most common is the addition of a small amount of a certain 
chiral selector to induce enantioselectivity (76% of the works reviewed, Figure 10A).[60–
62,64–66,44,67,69–71,73–75,78–80] ABS with biphasic chiral recognition, i.e. with two distinct 
chiral selectors that partition to opposite phases, have also been developed, based on the 
premise that these may yield greater separations. [63,68,72,76,77] Most of the reported 
enantioselective ABS resolved drugs (71% vs. 29% with amino acids – Figure 10B). Over 
50% of the works opted for β-CD or its derivatives as chiral selector (Figure 10C). The 
chemical structure of the racemates resolved is shown in Figure 11. 
Throughout this section, the enantioselective separation of chiral drugs and amino 
acids using ABS is overviewed. Two main parameters were used in literature to evaluate 
the enantioselectivities attained: the selectivity (α – Eq. 1) and the enantiomeric excess 
(e.e.% – Eq. 2). The α is the ratio between the partition coefficients of the enantiomers 
toward one phase, meaning that certain separation occurs if α > 1. e.e.% is the extent at 
which a mixture is enriched in one enantiomer rather than in the other, i.e. a mixture with 
an e.e.% of 50% is composed of 75% of one enantiomer and 25% of the other enantiomer. 
𝛼 =
[𝑅1] [𝑅2]⁄
[𝑆1] [𝑆2]⁄
=
𝐾𝑅
𝐾𝑆
     (Eq. 1)  𝑒. 𝑒. % =
[𝑅1]−[𝑆1]
[𝑅1]+[𝑆1]
100     (Eq. 2) 
 
[𝑅1] and [𝑅2] are the R-enantiomer concentration in phases 1 and 2, respectively. [𝑆1] 
and [𝑆2] are the S-enantiomer concentration in phases 1 and 2, respectively. 𝐾𝑅 and 𝐾𝑆 
 22 
 
are the partition coefficients of R-enantiomer and S-enantiomer, respectively, for phase 
1. 
 
Figure 10. Schematic representation of the data published on this field. Statistical data is organized 
according to (A) type of chiral recognition approach; (B) type of racemic mixture; and (C) type of chiral 
selector. 
 
Figure 11. Name, abbreviation and chemical structures of the drugs and amino acids evaluated so far in 
literature. 
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2.1.2.2.1. Drugs   
A considerable amount of the works overviewed dealing with racemic drugs has 
been devoted to the separation of mandelic acid (MA) enantiomers or their derivatives. 
The resolution approaches proposed cover ABS mainly composed of 
polymer/salt,[60,64,66,69] surfactant,[61] ethanol/salt[62] and IL/salt[65] combinations with the 
introduction of β-CD or its derivatives as chiral selectors.  
PEG + salt ABS containing β-CD or Cu2-β-CD as chiral selectors were proposed, 
motivated by a theoretical background involving the three-point model and the different 
stability and solubility between the PEG- and salt-rich phases of the inclusion 
complexes.[60,64] PEG + (NH4)2SO4 + β-CD yielded a maximum separation factor of 2.46 
for the (L)-enantiomer (30 wt% PEG 2000 + 20 wt% (NH4)2SO4, with [β-CD] = 0.008 
mol.L-1, [MA] = 0.05 mol.L-1 at pH 1.0 and 30ºC).[60] Bearing one carboxylic group and 
one aromatic group (Figure 11), MA suffers speciation with pH. Since β-CD has a higher 
recognition ability for molecular MA than for the ionic form, systems with pH values 
higher than 3 hampered an efficient enantioseparation.[60] Lower temperatures in a range 
of 30 to 70 ºC maintain the stability of β-CD-MA complexes. Lower initial concentrations 
of β-CD and MA enantiomers, where no cooperation between the two diastereomeric 
complexes and PEG occurs, are optimal. Lower molecular weights of PEG are ideal 
because they are less viscous, which consequently helps the phase-separation. Li and Li 
resolved a racemate of α-cyclohexylmandelic acid (α-CHMA) with PEG + Na3C6H5O7 + 
Cu2-β-CD ABS.[64] With preferential recognition ability for the R-CHMA, the developed 
system containing Cu2-β-CD reached a maximum separation factor of 1.36 (pH = 8.96, T 
= 9 ºC and [Cu2-β-CD] = 1 g) after optimization. Like MA, α-CHMA is also sensitive to 
pH changes due to the presence of one carboxylic group and one hydroxyl group in its 
structure, thus being dissociated in aqueous solution (Figure 11). Since Cu2-β-CD is only 
stable in alkaline conditions, the pH influence on the enantioselectivity was investigated 
in a pH range from 8 to 12. An optimal enantioselectivity was attained at 8.96, where 
monovalent CHMA, for which Cu2-β-CD has better chiral recognition ability and affinity, 
is present. With the increase in the pH, increases the concentration of divalent CHMA, 
which seems to be limiting the formation of inclusion complexes. Furthermore, the 
“CHMA-Cu2-β-CD” complex formation is also influenced by changes in temperature, 
since the separation factor decreases while increasing temperature from 9 to 60 ºC. The 
poorer stability of the two diastereomeric complexes and enhanced CHMA ionization at 
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higher temperatures contribute to this scenario. Finally, increasing Cu2-β-CD 
concentrations, up to 1 g per ca. 20 g of ABS, remarkably boosted the separation factor. 
To overcome the problems presented by ABS of polymeric basis, other ABS were 
proposed, namely aqueous micellar biphasic systems (AMBS), ethanol/salt-based 
ABS,[62] and IL/salt ABS.[61,65] AMBS are specific types of ABS that use surfactants and 
their capacity to form micelles/aggregates, and their aptitude to undergo two-phase 
separation in aqueous solution by temperature manipulation. AMBS based on Triton X-
114 with Cu2-β-CD as chiral selector for the enantioseparation of racemic MA led, under 
optimal conditions (8 wt% triton X-114 + [Cu2-β-CD] = 10 mmol L−1 + [MA] = 5 mmol 
L−1 at pH = 12 and T = 55 ºC) to an e.e.% of 67.91%, the highest value ever reported in 
literature (cf. Table 5).[61] As mentioned before, Cu2-β-CD is stable only in alkaline pH 
and it was observed that e.e.% values increased with pH up to 12. Again, the highest 
recognition ability of Cu2-β-CD for ionic MA is clear.[64] The concentration of Cu2-β-CD 
and, mainly temperature, were the main operational factors affecting the MA chiral 
recognition. Both R-MA and S-MA form complexes with Cu2-β-CD, being the higher 
maximization of the e.e.% detected at 10 mmol L−1 of chiral selector. In what concerns 
the effect of temperature, it seemed that a temperature of 55 ºC favoured 
enantioseparation due to the better stability of “Cu2-β-CD-(S)-MA” complexes than that 
of the “Cu2-β-CD-(R)-MA”. 
It was also proposed an ABS for the separation of racemic MA and α-CHMA 
composed of polar alcohols and salts, K2HPO4 and (NH4)2SO4, with sulfonated β-CD (Sf-
β-CD) with different degrees of substitution as the chiral selector.[62] These ABS, 
particularly these made of ethanol + (NH4)2SO4, were only able to chiral recognition of 
MA. The degree of substitution of the chiral selector, the system composition, the alcohol 
type, the MA concentration, temperature and pH were the conditions evaluated. β-CD 
sulfonated with 80 wt% of H2SO4 yielded the best results among all Sf-β-CD tested 
(sulfonated with 90 wt% or 70 % of H2SO4). The optimal system was defined as being 
composed of 30 wt% of ethanol + 15 wt% of (NH4)2SO4 + [Sf-β-CD] = 20 mmol.L-1, with 
[MA] = 0.5 mmol.L-1 at T = 50 ºC and pH = 2.0. For the optimum system, one α of 1.69 
and e.e.% of 16.3% were obtained, however, these values for MA are lower than the ones 
obtained in PEG 2000 + (NH4)2SO4 (α = 2.46 – see Table 5 for comparison). 
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IL-based ABS were suggested by Chen et al. for the chiral separation of α-CHMA 
enantiomers. Hydroxypropyl-β-cyclodextrin (HP-β-CD) was introduced as chiral selector 
in an ABS formed by ILs and (NH4)2SO4. Among the three ILs tested, [C4mim][BF4] was 
the most promising, yielding a maximum separation factor of 1.59 (17.09 wt% 
[C4mim][BF4]) + 14.05 wt% (NH4)2SO4 at T = 5ºC and pH = 4.36, [HP-β-CD] = 0.21 
g).[65] HP-β-CD, which has a preferential affinity to the enantiomer S, was reported as 
being mainly located in the salt-rich phase, which promoted the CHMA partition for that 
phase. While temperature was shown to have a clear trend on the impact upon 
enantioseparation, the remaining parameters investigated (pH, amount of IL, amount of 
salt and HP-β-CD) were characterized by maximum peak values. The authors argued that, 
between 5 and 50 ºC, the higher temperatures limited the enantioseparation of the ABS 
that promoted the CHMA partition towards the [C4mim][BF4]-rich phase. Moreover, as 
for other works reported for MA enantiomers,[60] HP-β-CD has better recognition for the 
molecular form, thus acidic pH would be favourable for enantioseparation. They reported 
that while pH between 1.5 and 4.36 improves enantioselectivity, it then decays as the pH 
is further increased up to 7. The authors attributed this behaviour to the higher affinity for 
the [C4mim][BF4]-rich phase exhibited by the molecular MA present at acidic pH. Giving 
the results obtained in the two works aimed at resolving enantiomers of CHMA,[64,65] IL-
based ABS revealed boosted performances (α = 1.59 versus α = 1.36 reported for 
polymer/salt ABS,[64] while the alcohol/salt ABS[62] were unable to recognize chiral 
CHMA).  
Tan and his collaborators[63] proposed an ABS for the enantiomeric resolution of 
MA using a polymer as both phase former and chiral selector to minimize the number of 
chemicals in the process. The chiral and thermo-sensitive polymer, poly(MAH-β-CD-co-
NIPAAm), was synthesized by the copolymerization of N-isopropylazylamide 
(NIPAAm) with β-cyclodextrin (β-CD) modified maleic anhydride (MAH).[63] This 
presented preferential recognition for the (S)-enantiomer. In combination with dextran 
T40, the ABS with this newly synthesized chiral polymer yielded a maximum separation 
factor of 1.27 under the optimum conditions (10 wt% poly(MAH-β-CD-co-NIPAAm) + 
10 wt% dextran T40 + [MA] = 0.010 mol.L-1 at T = 5ºC and pH = 2.04). Acidic pH, in 
particular a pH of 2, increased the separation factor due to the better recognition ability 
for the molecular MA as revealed in other works using CD derivatives as chiral 
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selectors.[60] Given the thermosensitive nature of poly(MAH-β-CD-co-NIPAAm), the 
temperature was identified as being an important parameter on the enantioseparation 
process proposed. Actually, temperatures higher than the optimal value of 10 ºC were 
suggested to be responsible for the poorer MA enantiomers recognition. On the other 
hand, the poly(MAH-β-CD-co-NIPAAm) was designed to be easily recycled and reused, 
as schematized in Figure 12. Although revealing the lower separation factors among the 
ABS studied (cf. Table 5),[60,61,64,65] this approach is more appealing regarding the 
environmental and economic impacts, not only due to its simpler nature, but also due to 
its proved reuse of the phases components. 
 
 
Figure 12. Schematic diagram of a chiral separation of MA enantiomers using a chiral ABS containing a 
thermo-sensitive polymer, as both phase former and chiral selector. Poly(MAH-𝛽-CD-co-NIPAAm) , (S)-
MA , (R)-M A . Adapted from [63]. 
 
Phenylsuccinic acid (PSA) enantiomers have also been resolved using chiral ABS. 
This molecule is important as antitumoral agent. Systems containing ethanol and 
ammonium sulphate, (NH4)2SO4, and HP-𝛽-CD (hydrophilic chiral selector) were 
employed. The separation factor reached 1.42, under optimized conditions (18.85 wt% 
(NH4)2SO4 +27.50 wt% ethanol + [HP-𝛽-CD] = 0.08 mol.L-1, with [PSA] = 1.0 mmol.L-
1 at T = 6 ºC and pH = 2.5) in a single step.[44] PSA enantiomers are binary acids, with 
their anionic form ratio changing with pH. Therefore, separation factors are pH 
dependent. As the pH increased from 2.5 to 8 the separation factor to the ethanol-rich 
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phase drastically decreased, since the medium was more enriched in double charged 
anionic PSA rather than in the single charged or neutral forms. This is due to the HP-𝛽-
CD greater affinity to form enantiomer-selector complexes with molecular PSA, rather 
than with the ionic form. High concentrations of HP-𝛽-CD (from 0 to 0.12 mol.L-1) are 
an advantageous condition for the enantioseparation, with a maximum α occurring at 0.08 
mol.L-1 of HP-𝛽-CD. Concentrations of the chiral selector higher than this value were 
defined as almost deleterious to enantioseparation. The authors suggested that probably 
the excess of HP-𝛽-CD promoted the S-PSA partition towards the salt-rich phase. 
Meanwhile, the separation factor decreased with increasing concentration of PSA. In 
summary, the authors argued that a balance between high and low concentrations of HP-
𝛽-CD and PSA, respectively, lead to the success of PSA enantiomers resolution. Finally, 
the temperature showed a favourable effect for chiral separation efficiency if decreased 
from 20 to 5 ºC.  
Aqueous two-phase flotation (ATPF) is a specific type of ABS that combines the 
principles of ABS formation and solvent sublation.[112] Racemic PSA was resolved with 
an aqueous two-phase flotation system formed by combinations of either alcohols + 
(NH4)2SO4 or PEG + (NH4)2SO4 with HP-𝛽-CD, where the air bubbles direct both the 
inclusion complexes and free PSA enantiomers to the interface for further partitioning.[66] 
The alcohols + (NH4)2SO4-based ABS were abandoned due to poor enantioselectivity or 
lack of stability to form an ATPF. The optimal conditions (40 wt% of PEG + 20 wt% of 
(NH4)2SO4 + [HP-𝛽-CD] = 0.015 mol.L-1, with a PEG of molecular weight of 2000 g.mol-
1 at pH = 2.5, air flow rate = 20 mL.min-1 and flotation time = 1 h) lead to a maximum α 
of 1.99. The recognition mechanism was based on the formation of “HP-β-CD-PSA” 
inclusion complexes, more significant for R-PSA. The enantioseparation process was also 
promoted by the partition of the complexes and free PSA between the two phases. It was 
also possible to make this type of ethanol/salt-based ABS more efficient in the 
enantioseparation of PSA by adopting the biphasic recognition concept.[67] Besides HP-
β-CD, also L-(+)-tartaric acid diisopropyl ester (L-IPTA) as chiral selector was used. 
While the HP-β-CD is mainly located in the salt-rich phase, L-IPTA partitions for the 
ethanol-rich layer. Under the optimized conditions selected (31.47 wt% of ethanol + 
15.41 wt% of (NH4)2SO4 + [l-IPTA] = 0.12 mol.L
-1 + [HP-𝛽-CD] = 0.06 mol.L-1, with 
[PSA] = 1.0 mmol.L-1, at pH = 2.5 and T=10ºC), a separation factor of 4.06 was achieved, 
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much higher than that of 1.42 obtained by the monophasic recognition ABS.[44] The same 
optimization parameters (pH, chiral selectors concentration, PSA initial amount and 
temperature) have a similar influence to that observed for the process based on 
monophasic recognition (ethanol +(NH4)2SO4 + HP-𝛽-CD).[44] Like HP-β-CD, also L-
IPTA is more able to recognize molecular PSA, making pH > 2.5 bad for 
enantioseparation. Moreover, the possibility of L-IPTA molecules interacting with HP-β-
CD appears for high concentrations of the chiral selector. Finally, it was proposed a less 
technologically complex alternative by using ABS composed of 𝛽-CD derivatives 
(sulfobutyl ether, SBE-𝛽-CD, and carboxymethyl, CM-𝛽-CD), acting both as phase 
former and chiral selector, and acetone. With the help of 3D response surface, it was 
possible to identify the optimized conditions (with 66.86 wt% acetone + 6.63 wt% of 
SBE-β-CD with [PSA] = 2.0 mmol.L-1 at T = 15 ºC and pH = 3.0) that yielded a separation 
factor of circa 3.1 (experimentally confirmed).[68] Although less efficient than the ABS 
operating in the biphasic recognition mode, this approach is better than that using 
monophasic recognition with the extra addition of HP-β-CD.[44,67] Moreover, with the 
exception of ethanol + (NH4)2SO4 + HP-𝛽-CD,[44] ethanol + (NH4)2SO4 + HP-𝛽-CD + L-
IPTA and acetone + SBE-𝛽-CD-based ABS are more efficient than traditional biphasic 
recognition ELLE (octanol + water + L-iso-butyl tartrate + HP-𝛽-CD with α = 2.86)[113] 
and aqueous two-phase flotation system (PEG + (NH4)2SO4 + HP-𝛽-CD with α = 1.99)[66]. 
Ofloxacin (OFLX) is a large-spectrum antibiotic, whose S-enantiomer is 8 to 128 
times and twice more effective at inhibiting Gram positive or Gram negative bacteria than 
the R-enantiomer and racemate, respectively.[114] It is thus of relevance to obtain OFLX 
in its enantiopure state as attempted by Arai and Kuroda[70] in the early 90s. ABS 
composed of two polymers, 40.7 wt% PEG 6000 + 8 wt% dextran T40, operating in 
counter-current mode were studied. Bovine serum albumin (BSA) at 6 wt% was used in 
this work as chiral selector and it was defined to be present in the dextran-rich phase. 
Proteins, since they are inherently chiral, highly stable and biocompatible can be useful 
chiral selectors to implement in bio-inspired enantiseparation processes.[115] The counter-
current mode allowed improving the e.e.% from 1% up to 62% for the R-OFLX after 8 
fractions collected. By extracting with methanol and followed by thin-layer 
chromatography, the authors were able to obtain optically enriched OFLX from the 
dextran-rich phase with a recovery of 71%. The applicability of the proposed process was 
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investigated with the resolution of racemates of the hypoglycemic agent midaglizole 
(DG-5128) and the β-blocker carvedilol using another chiral discriminator, the protein 
ovomucoid with no success. Shinomiya et al (1998) also employed BSA as chiral selector 
in ABS operating in counter-current chromatographic mode for the enatioseparation of 
D,L-KYN. The system selected was composed of 10 wt% of PEG 8000, 5 wt% Na2HPO4 
and 6 wt% of BSA and yielded a peak resolution of 0.94.[73] The authors have 
demonstrated that the BSA partitioned more significantly with the mobile phase, while 
the enantiomers mainly interacted with the column. The L-KYN has higher affinity for 
BSA, thus eluting before the D isomer. 
As mentioned above, the combined use of chiral selectors (the so-called biphasic 
recognition – Figure 4) may be beneficial to improve enantioseparation processes.[69] 
Within the domain of chiral ABS, the first report on biphasic recognition used L-tartaric 
acid (L-TA) and HP-𝛽-CD in systems composed of PEG + (NH4)2SO4. HP-𝛽-CD has a 
stronger affinity for the salt-rich phase due to its enhanced hydrophilicity, while L-tartaric 
acid remains in the polymer-rich layer. The authors proved that the mixture of L-tartaric 
acid and HP-𝛽-CD was improving the enantioseparation. The best system selected was 
composed of 40 wt% of PEG 2000, 25 wt% of (NH4)2SO4, [HP-𝛽-CD] = 0.02 mol.L−1, 
[L-tartaric acid] = 0.05 molL−1 at pH = 4,) and yielded a maximum 𝛼 of 1.32, in one step 
of extraction.[69] At acidic conditions, especially of pH 4, the amount of protonated OFLX 
increased and thus, the enantiomers and the chiral selectors interacted more strongly. A 
careful balance between the chiral selectors content must be achieved, since opposite 
patterns are obtained for HP-𝛽-CD and L-tartaric acid. Higher concentration of the former 
(0 – 0.04 mol.L-1, with a maximum α at 0.02 mol.L-1) precludes enantioseparation due to 
its hydrophilicity, not only forcing the partition of OFLX enantiomers to the salt-rich 
phase, but also promoting the occurrence of interactions with the L-tartaric acid that will 
hinder the “OFLX-HP-𝛽-CD” complexation. Higher amounts of the later (0 – 0.05 mol.L-
1, with a maximum α at 0.05 mol.L-1) induce favourable interactions between OFLX 
enantiomers and L-tartaric acid, hence partitioning to the PEG-rich phase. 
Flurbiprofen (FLU) belongs to the non-steroidal anti-inflammatory drugs and has 
analgesic and antipyretic activities. It is widely used to manage rheumatoid arthritis.[116] 
It is still marketed in its racemic form, although there are evidences for the distinct 
activities of the enantiomers.[117] ABS composed of ethanol and (NH4)2SO4, coupled to 
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biphasic recognition with L-dioctyl tartrate, (L-DOT) and L-tryptophan (L-Trp) were 
used to resolve racemic FLU. These two chiral selectors were chosen among amino acids, 
β-CD derivatives, and L-tartrate esters. The maximum α attained for FLU enantiomers 
was 2.34 (on a system composed of 35 wt% of ethanol + 18 wt% of (NH4)2SO4 with [L-
DOT] = 80 mg, [L-Trp] = 40 mg, [FLU]=0.10 mmol.L-1, at pH  = 4.0 and T = 25 °C).[71] 
L-DOT and L-Trp enantioselectively recognized R- FLU and S- FLU in ethanol-rich and 
(NH4)2SO4-rich phases, respectively. The L-DOT concentration enhanced the separation 
factor for the R-enantiomer, while the L-Trp showed no significant enantiomeric 
recognition for any of the enantiomers. The best enantioselectivity achieved was under 
acidic conditions at pH 4, where both neutral and anionic FLU forms were present in an 
equimolar ratio. The authors showed that for this specific case, temperature had no 
significant impact on the enantioselectivity. Moreover, it was proved that the FLU 
concentration was limited by the amount of chiral selector, revealing that the enantiomeric 
recognition mechanism was based on a complexation phenomenon. 
Wang et al. focused on the hypnotic agent zopiclone (ZPC). They have studied three 
β-CD derivatives, namely CM-β-CD, SBE-β-CD and HP-β-CD, both as chiral selectors 
and phase forming components in a ABS with hydrophilic organic solvents (alcohols and 
acetonitrile).[72] The desired opposite partitioning behaviour of ZPC enantiomers was 
more significantly attained using the ABS composed of 1-propanol and CM-β-CD, which 
was further selected as the optimal system. Under the optimal conditions for S-ZPC 
(single step process using the system composed of 78.35 wt% of 1-propanol + 2.17 wt% 
of CM-β-CD with [ZPC] = 0.05 mmol.L-1, at T = 30 ºC and pH 8), the parameter α 
achieved was around 2.58 and the e.e.% was 32.66%. Contrarily to what had been widely 
described before, [68,72] the biphasic recognition, through the addition of L-tartaric acid 
derivatives was shown to be deleterious to enantioseparation of racemic ZPC. pH 8 led 
to the best enantioselectivity for S-ZPC, for which more than 50% of ZPC was present in 
its neutral form. Above and below this pH, the majority of the ZPC species in solution 
were charged (negative or positively charged, respectively). In these works, it was shown 
that the CM-β-CD molecules mainly showed chiral recognition ability and affinity for 
molecular ZPC. 
Finally, Ni et al. reported the enantioselective biotransformation of the antiallergic 
drug betahistine intermediate (S)-(4-Chlorophenyl)-(pyridin-2-yl)methanol, (S)-CPMA, 
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on ABS.[74] This reactive extraction method was based on the enantioselective 
metabolism of some specific microorganisms. Kluyveromyces sp. CCTCC M2011385 
was isolated for the stereoselective reduction of (4-chlorophenyl)-(pyridin-2-
yl)methanone (CPMK) to (S)-CPMA after testing other strains of carbonyl reductase-
producing microorganisms. This polymer/salt-based ABS reached 86.7% of e.e.% and 
92.1% of product yield, after optimization. The optimal conditions found were defined 
for the system composed of 20 wt% of PEG 4000 + 14 wt% of Na2HPO4, with 2g wet 
cells, 3% (w/v) of glucose, [CPMK] = 6 g.L-1 operating under T = 30 ºC for 48 h. In this 
work, both processes of biotransformation and enantioseletive extraction using ABS were 
conjugated. Their conjugation showed some advantages, since both hydrophobic 
substrate and product were accumulated in the PEG-rich phase, and with this, the 
inhibitory effect of the product and substrate over the microbial cells (located in the salt-
rich phase) was minimized. 
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Table 5. Summary of the best results of e.e.% and α obtained considering the use of different ABS applied in the extraction of drugs. n.d.- not determined 
Racemate 
ABS Phase Formers 
Chiral Selector 
Selectivity Parameters Refs. 
1 2 e.e.% α  
MA 
PEG 2000 (NH4)2SO4 β-CD n.d. 2.46 [60] 
Triton X-114 - Cu2-β-CD 67.91 n.d. [61] 
Ethanol (NH4)2SO4 Sf-β-CD 16.3 1.69  [62] 
Poly(MAH-β-CD-
co-NIPAAm) 
Dextran T40 Poly(MAH-β-CD-co-NIPAAm) n.d. 1.27 [63] 
α-CHMA 
PEG 6000 Na3C6H5O7 Cu2-β-CD n.d. 1.36 [64] 
[C4mim][BF4] (NH4)2SO4 HP-β-CD n.d. 1.59 [65] 
PSA 
PEG2000 (NH4)2SO4 HP-β-CD 23.49 1.99 [66] 
Ethanol (NH4)2SO4 HP-β-CD n.d. 1.42 [44] 
Ethanol (NH4)2SO4 L-IPTA + HP-β-CD 57.86 4.06 [67]  
Acetone SBE-β-CD SBE-β-CD 31.7 2.1 [68] 
OFLX 
PEG 2000 (NH4)2SO4 L-TA + HP-β-CD n.d. 1.32 [69] 
PEG 6000 Dextran T40 BSA 62 n.d. [70] 
FLU Ethanol (NH4)2SO4 L-DOT + L-Trp n.d. 2.34 
[71] 
ZPC 1-propanol CM-β-CD CM-β-CD 32.66 2.58 [72] 
KYN PEG 8000 Na2HPO4 BSA n.d. n.d. 
[73] 
(S)-CPMA PEG 4000  Na2HPO4 microbial cells 86.7 n.d. 
[74] 
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2.1.2.2.2. Amino acids  
 There is an industrial interest for natural amino acids in the food industry for 
animal feed, flavour agents and food supplements.[118] In the pharmaceutical industry, 
unnatural amino acids are used to produce medicines, such as the antagonist cetrorelix 
acetate.[119] The studied amino acids are mostly tryptophan[78–80] and phenylalanine, [75–
77] in ABS containing two polymers,[78] polymer + salt,[75,79] polar organic solvents + 
salt,[80] and, finally chiral ILs + salt.[76,77] As summarized in Table 6, the chiral selectors 
used were proteins,[78,79] β-CD derivatives[75,80] and chiral ILs (in this last case working 
as chiral selector and phase former).[76,77] Chen et al.[75] proposed an ABS for the 
resolution of the racemic phenylalanine and established the optimal chiral separation 
conditions. The system selected was composed of PEG 2000 and (NH4)2SO4 containing 
combined chiral selectors, namely β-CD and HP-β-CD. The biggest α and e.e.% achieved 
were 1.53 and 12.83% (β-CD:HP-β-CD ratio of 2:3 at pH = 5.5), respectively. The ABS 
showed an extractive ability, but no resolution ability in the absence of chiral selectors. 
Then, an improvement in α and e.e.% was observed using two selectors instead of a single 
one, in particular for β-CD:HP-β-CD ratio of 2:3 and increasing the total concentration 
of chiral selectors. At pH 5.5 (optimal pH and isoelectric point of Phe) the amino acid is 
present in its neutral form. HP-β-CD has worse recognition for the ionic Phe species, what 
justifies the improved enantioselectivity at this pH value.  
With IL-based ABS appears a good alternative to enantioseparation of racemic 
Phe with polymeric ABS. Wu et al. proposed the use of newly synthesized chiral modified 
imizadolium-based ILs ([ChiralFunct1C1im][PF6] and [ChiralFunct
2C1im][PF6]) and 
Na2SO4 to form ABS. The maximum e.e.% obtained was 53%, with the optimal system 
operating in the conditions: [ChiralFunct1C1im][PF6]:water volume ratio of 0.66 at 20 ºC 
for 6 h of IL-Phe contact.[76] Nuclear magnetic resonance (NMR) and discrete Fourier 
transform results showed that [ChiralFunct1C1im][PF6] interacts more and forms more 
stable complexes with D-Phe than with L-Phe. The wide applicability of this ABS was 
shown for other amino acids, but with lower e.e.% values (21 – 38%). In the end, the 
[ChiralFunct1C1im][PF6] was recovered by a simple methodology. Dissolving the 
[ChiralFunct1C1im][PF6] in acetonitrile, where amino acids are insoluble, the IL was 
regenerated and further applied keeping good enantioseletivity during at least 6 cycles. 
However, [PF6]
- is an hydrophobic and poorly stable anion in water. So, other ILs with 
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tropine as the cation, [CnTropine], and proline, [L-Pro], as the anion have been proposed. 
The ABS was formed in combination with the salting out agent K2HPO4. Under the most 
appropriate conditions (13 g.g-1 of [C8Tropine][Pro] + 30 g.g
-1 of K2HPO4 + 0.51 g.g
-1 of 
H2O + 0.035 g.g
-1 of Cu(Ac)2 with 0.020 g.g
-1 of D,L-Phe), the e.e.% was 65%.[77] Larger 
alkyl chain lengths on the cation [Cntrop] facilitated the access of D-Phe into the IL-rich 
phase, which indicated that the [C8trop][L-Pro] forms more stable ternary complexes with 
D-Phe, enhancing the e.e.%. This system had a particular aspect that is the formation of 
a third phase, in which the L-Phe was concentrated (at concentration of 0.015 to 0.020 
g.g-1 of D,L-Phe). Thus, D-Phe is concentrated in the IL-rich phase, and the insoluble 
interphase was enriched in the L-isomer. NMR studies confirmed that the complex 
between the IL and D-Phe was more stable than the complex between the IL and L-Phe. 
Moreover, this analysis led to the hypothesis that [C8trop][L-Pro] interacts by the three 
point model, forming a triangle involving [L-Pro]-, [C8trop]
+ and D-Phe with Cu2+ as the 
central atom. In summary, this system uses more environmentally friendly ILs and 
guarantees better enantiomeric excess than all the remaining systems used for racemic 
Phe resolution (65% > 53%[76] > 12.83%[75]) – see Table 6 for comparison.  
In 1985, Ekberg et al. developed an enantioselective ABS for separation of D,L-
Trp. The system was composed of dextran T40 and PEG 8000 and BSA was the chiral 
selector operating in counter current chromatography. The separation factor obtained was 
3.1, since L-Trp was more retained in the dextran-rich bottom phase, where BSA is 
present, than D-Trp.[78] A counter-current chromatography application of ABS for the 
separation of tryptophan enantiomers was proposed by Tong et al.[79] In this case, the 
system composed of 12 wt% of PEG 8000 + 9 wt% of K2HPO4 + 0.1 wt% of NH3 with 
BSA (6 wt%) as the chiral selector was applied. The results suggested that BSA was 
predominantly distributed in the salt-rich phase of the ABS. However, the authors have 
found many problems developing this process, mainly due to the low mass transfer rate 
observed and consequent lower resolution of the peaks. However, a relatively high α of 
2.605 was achieved. From here and the results reported on Table 6, PEG/dextran/BSA-
based system[78] were defined as more efficient than PEG/salt/BSA-based ABS[79].  
Chen and his collaborators[80] proposed an ABS composed of ethanol, (NH4)2SO4 and 
β-CD as a chiral selector. Under optimized extraction conditions (15.9 wt% of (NH4)2SO4 
+ 7 mL of ethanol + [β-CD] = 0.01 mol.L−1 at pH = 3 and T = 20 ºC), the highest value 
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of α obtained was obtained (1.38). The authors defined pH 3 as a parameter favouring the 
enantioseparation of D,L-Trp, since at this pH this amino acid is in its neutral form, which 
was facilitating the formation of complexes. The enantioseparation in this ABS was based 
on the differential solubilities of β-CD and Trp in the two phases. Contrarily to Trp, β-
CD is not very soluble in ethanol. By complex formation with β-CD, Trp starts to partition 
to the salt-rich phase. 
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Table 6. Summary of the optimal results obtained for the enantioselective ABS applied in the extraction of amino acids. n.d.- not determined 
Racemate 
Pair of Phase Forming Agents 
Chiral Selector 
Selectivity Parameters  
1 2 e.e.% α  
Phe 
 
PEG 2000 (NH4)2SO4 β-CD+HP-β-CD 12.83 1.53 [75] 
[ChiralFunct1C1im][PF6] Na2SO4 [ChiralFunct
1C1im][PF6] 53 n.d. 
[76] 
[C8tropine][L-Pro] K2HPO4 [C8tropine][L-Pro] 65 n.d. 
[77] 
Trp 
 
PEG 8000 Dextran T40 BSA n.d. 3.1 [78] 
PEG 8000 K2HPO4 BSA n.d. 2.605 
[79] 
Ethanol (NH4)2SO4 β-CD n.d. 1.38 [80] 
Tyr [ChiralFunct1C1im][PF6] Na2SO4 [ChiralFunct
1C1im][PF6] 38 n.d. 
[76] 
Thr [ChiralFunct1C1im][PF6] Na2SO4 [ChiralFunct
1C1im][PF6] 29 n.d. 
[76] 
Ser [ChiralFunct1C1im][PF6] Na2SO4 [ChiralFunct
1C1im][PF6] 21 n.d. 
[76] 
Asp [ChiralFunct1C1im][PF6] Na2SO4 [ChiralFunct
1C1im][PF6] 29 n.d. 
[76] 
Ile [ChiralFunct1C1im][PF6] Na2SO4 [ChiralFunct
1C1im][PF6] 34 n.d. 
[76] 
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2.2. Carbohydrates and amino acids as chiral selectors in IL-based 
ABS 
Most commonly, pairs of polymers or of a polymer and a salt are the choices to 
form ABS. Nonetheless, multiple other pairs of compounds were proposed in the last 
decades, such as those bearing carbohydrates and amino acids.[19] Several authors have 
reported the use of carbohydrates[68,72,46,81–87] and amino acids[90,47,91,92] as phase forming 
components in ABS, as overviewed in section 2.1.2.1.1. However, very few[68,72] took 
advantage of carbohydrates or amino acids as chiral phase formers able to act as chiral 
selectors for the resolution of racemates, as highlighted in section 2.1.2.2.  
Given the ready availability of the two enantiomeric forms of amino acids and 
sugars alongside with the low price of their natural form, ABS composed of these can be 
considered an inexpensive chiral pool for resolution studies. Therefore, this chapter 
evaluates the potential of carbohydrates and amino acids as ABS simultaneously phase 
forming agents and chiral selectors in the resolution of MA enantiomers. The role of six 
carbohydrates was studied using ABS composed of [C4mim][CF3SO3] reported in 
literature. Also, two different amino acids (L-lysine and L-proline) were investigated in 
ABS composed of [C4mim][CF3SO3] and [P4444]Br. Additionally, amino acids-based 
ABS were used to assess the effect of distinct ILs on the partitioning of MA enantiomers. 
 
2.2.1.  Experimental section 
2.2.1.1. Chemicals/Materials 
The carbohydrates used in this work were D-glucose purchased from AnalaR, D-
fructose (purity > 98%) from Panreac, D-maltose (purity > 98%) and D-xylose (purity > 
99%) both purchased from Sigma-Aldrich, D-sucrose (purity > 98%) from Prolabo and 
D-sorbitol (purity = 91.0% - 100.5%) from Fisher Bioreagents. Two amino acids were 
used, namely L-lysine (purity > 98%) and L-proline (purity > 99%) both acquired from 
Acros Organics. The ILs used were 1-butyl-3-methylimidazolium 
trifluoromethanesulfonate, [C4mim][CF3SO3] (purity > 99%), 1-butyl-3-
methylimidazolium tetrafluoroborate, [C4mim][BF4] (purity > 99%) and 1-butyl-3-
methylimidazolium dicyanamide, [C4mim][N(CN)2] (purity > 98%) supplied from Iolitec 
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and tetrabutylphosphonium, bromide [P4444]Br (purity > 96%) from Cytec. The chemical 
structures of the carbohydrates, amino acids and ILs used in the preparation of the ABS 
are shown in Figure 13. 
The enantiomers used to carry out the partition studies were (R)-(-)-mandelic acid, 
R-MA (purity = 99%), and (S)-(+)-mandelic acid, S-MA (purity = 99%), both supplied 
by Acros Organics. Their chemical structure is represented in Figure 14. 
For the HPLC-DAD analysis of the enantiomers, copper (II) sulphate 
pentahydrate, CuSO4·5H2O (purity > 98%), L-Phenylalanine, L-Phe (purity > 98%), 
purchased from AnalaR and Sigma-Aldrich, respectively, and methanol (HPLC grade), 
acquired from CHEM-LAB, were used for the mobile phase. The water used for the 
HPLC analysis was ultra-pure water, double distilled and then treated with a Milli-Q plus 
185 water purification apparatus. Syringe filters (0.45 μm) and regenerated cellulose 
membrane filters (0.45 μm), acquired at Specanalitica and Sartorius, respectively, were 
using during filtration steps.  
 
 
Figure 13. Name, abbreviation and chemical structure of the ILs, amino acids and carbohydrates evaluated 
in this section. 
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Figure 14. Chemical structure of MA enantiomers. 
 
2.2.1.2. Experimental methods 
2.2.1.2.1. Partition of MA enantiomers in ABS composed of IL/carbohydrates and 
IL/amino acids 
To evaluate the partition behaviour of MA enantiomers between the coexisting 
phases of the ABS, mixture points were selected in the biphasic region of phase diagrams 
previously reported in literature.[46,47] The extraction points selected for the amino acid-
based ABS are reported in Tables 7 and 8 and the appropriate amounts of each phase 
forming agent were added. R-MA and S-MA aqueous solutions (0.05 g.mL-1) were added 
in equal amounts at a final mass fraction in the ABS of ca. 0.8 wt% of each enantiomer. 
To promote the contact between the enantiomers and the ABS chiral phase formers 
(amino acids or carbohydrates), racemic mixture + amino acid/carbohydrate solutions 
were left overnight as recommended by Wu et al.[76] The remaining phase forming 
components were then added and all mixtures were stirred vigorously and placed for at 
least 18h at 25 (±1)ºC to reach the thermodynamic equilibrium between the two phases 
and to ensure the mandelic acid complete partitioning. The two phases were then 
separated, collected to weight measurement (within an uncertainty of ±10-4 g), and then 
filtered with syringe filters for HPLC-DAD quantification. 
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Table 7. Conditions studied, approximate mass fraction compositions (in percentage) and phases’ 
identification for the carbohydrate-based partition systems investigated. 
 
Table 8. Conditions studied, approximate mass fraction compositions (in percentage) and phases’ 
identification for the amino acid-based partition systems investigated. 
ABS 
Top 
phase 
Bottom 
phase 
mass fraction 
composition (wt%) 
Ref 
Amino acid IL Amino acid IL 
L-Lysine [C4mim][CF3SO3] AA-rich IL-rich 15 30 
[47] L-Lysine [C4mim][BF4] AA-rich IL-rich 15 30 
L-Lysine [C4mim][N(CN)2] IL-rich AA-rich 15 45 
L-Lysine [P4444]Br IL-rich AA-rich 15 45 [120] 
L-Proline [C4mim][CF3SO3] AA-rich IL-rich 25 40 [47] 
L-Proline [P4444]Br IL-rich AA-rich 15 60 [120] 
 
2.2.1.2.2 Mandelic acid enantiomers quantification by HPLC-DAD 
The quantification of MA enantiomers was done by HPLC-DAD using an 
analytical method previously developed and validated in our research group, adapted 
from Yue et al.[121] The liquid chromatograph HPLC Elite LaChrom (VWR Hitachi) used 
was composed of a diode array detector (DAD) l-2455, column oven l-2300, auto-sampler 
l-2200 and pump l-2130. The analytical column used was purchased from Merck and was 
constituted by a sorbent LiChrospher 100 RP-18 (5μm) and cartridge LiChroCART 250-
4 HPLC-Cartridge, connected to a 5 μm, 4 mm × 4 mm guard column containing the same 
stationary phase. The mobile phase composition for the column was the following: 
ABS 
Top 
phase 
Bottom 
phase 
mass fraction 
composition (wt%) 
Ref 
Carbohydrate IL Amino acid IL 
D-Fructose 
[C4mim][CF3SO3] 
CH-rich IL-rich 
25 40 [46] 
D-Glucose CH-rich IL-rich 
D-Sorbitol CH-rich IL-rich 
D-Xylose CH-rich IL-rich 
D-Maltose CH-rich IL-rich 
D-Sucrose IL-rich CH-rich 
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methanol:water (15:85) containing 2 mM of L-Phe and 1 mM of CuSO4. The pH of 
mobile phase was adjusted to 4.00 (±0.01) by adding ammonia aqueous solution at 5 wt%. 
The mobile phase was then filtered under vacuum using regenerated cellulose membrane 
filters (0.45 μm) and degassed in an ultrasound bath. In here, the stationary phase is 
achiral and is the mobile phase, due to the presence of L-Phe and Cu2+, which promotes 
the chiral separation within the chromatographic column. 
The chromatographic separation was carried out under an isocratic elution with a 
flow-rate of 0.8 mL.min-1. The injection volume was 20 μL and the DAD detector was 
set to measure at 270 nm. 22 °C and 25 °C were the temperatures at which the column 
oven and the autosampler operated. The HPLC-DAD quantification was based on a 
calibration curve (Appendix A) for each of the enantiomers determined with standard 
solutions of known concentration (10 – 500 μg.mL-1) prepared in methanol:water (15:85) 
using the respective peak areas. Retention times of both enantiomers differ, with R-MA 
eluting first at 11 min followed by S-MA at 13 min. MA standard solutions were routinely 
injected to guarantee a correct quantification.  
To evaluate the extraction performance, two parameters were calculated, the 
enantiomeric excess value (e.e.%) (Eq. 3,5) and the extraction efficiency (EE) defined by 
Eq. 4,6. 
 
Amino acid/IL-based ABS:  𝑒. 𝑒. % =
𝑚𝑅−𝑀𝐴
𝐴𝐴−𝑟𝑖𝑐ℎ−𝑚𝑆−𝑀𝐴
𝐴𝐴−𝑟𝑖𝑐ℎ
𝑚𝑅−𝑀𝐴
𝐴𝐴−𝑟𝑖𝑐ℎ+𝑚𝑆−𝑀𝐴
𝐴𝐴−𝑟𝑖𝑐ℎ100  (Eq. 3) 
Amino acid/IL-based ABS: 𝐸𝐸𝑀𝐴,𝑎𝑎−𝑟𝑖𝑐ℎ(%) =   
𝑚𝑅/𝑆−𝑀𝐴
𝐴𝐴−𝑟𝑖𝑐ℎ
𝑚𝑅/𝑆−𝑀𝐴
0 × 100  (Eq. 4) 
Carbohydrate/IL-based ABS:  𝑒. 𝑒. % =
𝑚𝑅−𝑀𝐴
𝐶𝐻−𝑟𝑖𝑐ℎ−𝑚𝑆−𝑀𝐴
𝐶𝐻−𝑟𝑖𝑐ℎ
𝑚𝑅−𝑀𝐴
𝐶𝐻−𝑟𝑖𝑐ℎ+𝑚𝑆−𝑀𝐴
𝐶𝐻−𝑟𝑖𝑐ℎ100  (Eq. 5) 
Carbohydrate/IL-based ABS: 𝐸𝐸𝑀𝐴,𝐶𝐻−𝑟𝑖𝑐ℎ(%) =
𝑚𝑅/𝑆−𝑀𝐴
𝐶𝐻−𝑟𝑖𝑐ℎ
𝑚𝑅/𝑆−𝑀𝐴
0 × 100   (Eq. 6) 
 
𝑚𝑅/𝑆−𝑀𝐴
𝐴𝐴−𝑟𝑖𝑐ℎ is the mass of the MA enantiomer on the amino acid-rich phase, 
𝑚𝑅/𝑆−𝑀𝐴
𝐶𝐻−𝑟𝑖𝑐ℎ is the mass of the MA enantiomer on the carbohydrate-rich phase and 𝑚𝑅/𝑆−𝑀𝐴
0  
is the initial mass of the MA enantiomer added to the system. For the IL/carbohydrate 
ABS used, the top phase is carbohydrate-rich and the lower phase is IL-rich, aside from 
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the sucrose system as reported in Freire et al.[46] work and confirmed by conductivity 
measurements. For the IL/amino acid ABS,[47] this condition changed depending on the 
system. Only the chiral selector-rich phases were considered in data interpretation.  
 
2.2.1.2.3. Identification of the phases 
Conductivities to identify the top and bottom layers as being CH/AA-rich or IL-
rich were determined using a Crison GLP 31 EC meter with a conductivity cell + pt 1000. 
The identification of the IL-rich phase in IL/amino acid-based ABS containing 
imidazolium-based ILs was done by UV spectroscopy at circa 210 nm using a 
SHIMADZU UV-1700 Pharma-Spec spectrometer. Non-aromatic IL rich phases were 
identified by conductivity/RMN. 
 
2.2.1.2.4. pH determination 
The pH (± 0.02) of the ABS coexisting phases and the HPLD-DAD mobile phase 
was determined using a Metrohm 827 pH meter.   
2.2.2.  Results and discussion 
2.2.2.1. Partition studies of MA enantiomers 
A screening of chiral ABS composed of carbohydrate + IL + H2O
[46] and amino 
acid + IL + H2O
[47] was performed for the extraction of MA enantiomers. Only the chiral 
selector-enriched phases (i.e. carbohydrate-rich or amino acid-rich) were considered. The 
detailed data obtained for the enantiomeric excess and extraction efficiencies is available 
in Appendix B and C for carbohydrates and amino acids, respectively. 
In the carbohydrate/[C4mim][CF3SO3]-based ABS, with the exception of the 
system containing D-Maltose, MA displays a higher affinity for the IL-rich phase, the 
most hydrophobic phase. In general, it seems that the MA preferentially partitions to the 
IL-rich phase, independently of the sugar structure.  The higher affinity of MA for the 
most hydrophobic phase could actually be explained by the higher hydrophobicity of MA 
suggested by its octanol-water partition coefficient of around 6.31 (log P = 0.80)[122] more 
than by the possibility of salting-out effects normally ruling the partition of biomolecules 
between aqueous phases. Actually, D-Maltose with its unexpected behaviour proves this 
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theory, because despite its strongest salting-out nature[46] it drives the MA to 
preferentially partition to the D-Maltose-rich phase. This fact underpins that the partition 
is possibly caused by specific interactions between the MA and the main phase formers, 
and deserves further study in the future. Figure 15 displays the extraction and 
enantiomeric separation results of the carbohydrate based-ABS evaluated. It is possible 
to rank their aptitude to separate R-MA and S-MA as following (based on the e.e.% 
results): D-Fructose > D-Glucose > D-Sorbitol > D-Sucrose > D-Maltose > D-Xylose. 
Positive values of enantiomeric excess indicate a preferential interaction with R-MA, 
while negative values indicate a favourable interaction with S-MA. This type of system 
produced a diversified scenario, although enantiomeric excess did not surpass 10% in any 
case. Excepting for D-Xylose, monosacharides (D-Fructose and D-glucose) seem to be 
more efficient for MA enantioseparation than polyols (D-Sorbitol) and disaccharides (D-
Sucrose and D-Maltose). The best system was D-Fructose + [C4mim][CF3SO3] with an 
e.e.% of 9.3 ± 1.7% and the biggest difference between the EEMA,CH-rich for R-MA and S-
MA (36.4 ± 0.5% vs. 29.9 ± 1.2%, respectively). This result indicates the preferential 
interaction of D-fructose with the R-MA enantiomer. However, at the pH of this system 
(at ca. 5.3, Appendix D), fructose is present in its neutral form and MA in its anionic 
form.[123] It would be worth in the future to study the effect of the pH of the medium upon 
the separation in order to have molecular MA and thus enhance the interactions between 
neutral D-fructose and R-MA. 
In what regards the amino acid/IL-based ABS, the MA enantiomers partition 
patterns depend on both the amino acid and IL employed as shown in Figure 16. For the 
L-lysine + imidazolium based-IL systems, MA displays a higher affinity for the AA-rich 
phase. For the L-Proline + imidazolium based-IL the opposite trend was observed. L-
Lysine is more polar than L-Proline, since it has an additional –NH2 group in its side 
chain.[47] MA is present in its anionic[123] (Appendix E) form (which is more polar than 
the molecular MA)[123] at the pH of the ABS (Appendix B), being the partition dictated 
by the polarity of the amino acid. For the [P4444]Br based-ABS the partition was slightly 
higher for the AA-rich phase, in a similar manner, independently of the amino acid. 
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Figure 15. Extraction efficiencies (primary scale, bars, EEMA,CH-rich) obtained for R-MA () and S-MA () 
and the enantiomeric excess (secondary scale, , e.e.MA,CH-rich%) reached with the studied 
carbohydrate/[C4mim][CF3SO3]-based ABS.  
 
For the amino acid/IL-based ABS, the following trend for enantiomeric excess is 
observed: L-lysine + [C4mim][CF3SO3] > L-lysine + [C4mim][BF4] > L-proline + 
[C4mim][CF3SO3] > L-lysine + [C4mim][N(CN) 2] > L-lysine + [P4444]Br > L-proline + 
[P4444]Br (cf. Figure 16 A). Imidazolium-based ILs seem to be the best pairs to both amino 
acids, rather than [P4444]Br, for the enantioselective partition of racemic MA. In one hand, 
L-lysine is shown to be more efficient than L-proline for the [C4mim][CF3SO3]-based 
ABS. On the other hand, no difference was noted in the ABS containing [P4444]Br (cf. 
Figure 16AB).  
Figure 16A displays the effect of the IL with fixed amino acid. For L-lysine-based 
systems, MA enantiomers were preferentially extracted to the amino acid-rich phase, 
more notoriously when [C4mim][CF3SO3] was used. The L-lysine + [C4mim][CF3SO3] 
system possesses the highest e.e.% (5.8 ± 1.9%) as well as the most notorious difference 
between EEMA,aa-rich for R-MA and S-MA (75.2 ± 3.3% and 66.5 ± 4.8%, respectively). 
This result indicates the preferential interaction of L-lysine with R-MA enantiomer. 
Within the pH of these systems (around 10.3), MA is in its ionic form (Appendix E), 
while lysine is either zwitterionic or anionic. Neutralizing the pH of the system should 
favour the interaction between the molecules since lysine would have a global positive 
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charge, that could lead to a better recognition of anionic MA.[123] For the L-proline-based 
systems, MA enantiomers display similar affinities for both phases, revealing a  poor 
ability to separate the enantiomers. 
 
Figure 16. Extraction efficiencies (primary scale, bars, EEMA,aa-rich) obtained for R-MA () and S-MA () 
and the enantiomeric excess (secondary scale, , e.e.MA,aa.rich%) reached with the studied amino acids/IL-
based ABS: A, effect of the IL, B, effect of the amino acid. 
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2.3. Development of cationic CIL-based ABS 
Ionic liquids (ILs) are salts with low melting temperatures, by definition below 
100 ºC, that are composed of organic cations and inorganic or organic anions. They 
present several advantages of non-volatility, non-flammability, and thermal 
stability.[19,100] Commonly referred to as “designer solvents”,[101] ILs can be tailored to 
specific functions, thus expanding their applicability in the field of separation. By using 
chiral cations, anions or both, CILs can be developed to act as chiral selectors in many 
chiral applications,[102][102,108] such as for chiral ABS.[19]  
Previously, anionic CIL-based ABS have been studied for the enantioselective 
resolution of MA enantiomers, with limited success (maximum e.e.% of 12.4 ± 2.0%).[124] 
MA’s net charge within the pH range studied is mostly negative, being likely repelled 
from the chiral centres of anionic CILs. Taking this into account, the present chapter is 
dedicated at the development of enantioselective cationic CIL-based ABS for chiral 
resolution. Cationic CILs based on the quininium, proline and valinolium cations were 
synthesized and used in ABS simultaneously as phase forming components and chiral 
selectors for the resolution of MA. First, the phase diagrams of the ABS composed of 
distinct CILs + salts were determined and the partition of R-MA and S-MA further 
evaluated. The ABS developed allowed to infer on the CIL structure and role of the salt 
type on both phase formation and MA partition behaviour. 
2.3.1. Experimental section 
2.3.1.1.Chemicals/Materials 
Six cationic CILs were synthesized in this work: 1-methyl quininium 
methylsulfate, [C1Qui][C1SO4]; N,N-dimethyl-L-proline methyl ester iodide, 
[C1C1C1Pro]I; N,N-dimethyl-L-proline methyl ester methylsulfate, [C1C1C1Pro][C1SO4]; 
N,N-diethyl-L-proline ethyl ester bromide, [C2C2C2Pro]Br; N,N,N-trimethyl-L-
valinolium iodide, [C1C1C1Val]I; and N,N,N-trimethyl-L-valinolium methylsulfate, 
[C1C1C1Val][C1SO4]. These ILs were synthesized in our laboratory, according to well-
established protocols described by Sintra et al.[125] Their chemical structures and 
abbreviation names are shown in Figure 17. For the synthesis of the CILs, the reagents 
used were quinine (purity = 98%), iodomethane (purity = 99%), dimethyl sulfate (purity 
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= 99%), dichloromethane anhydrous (purity = 99.8%), ethanol (purity = 99.8%), acetone 
(HPLC grade), potassium carbonate (purity = 99%), L-proline (purity = 99%), 
bromoethane (purity = 98%), acetonitrile (purity = 99.8%), chloroform (purity = 99%), 
L-valine (purity = 98%), sodium borohydride (purity = 99%), sulfuric acid (purity = 
99.9%), methanol (purity = 99%), ethyl acetate (purity = 99.8%), potassium hydroxide 
(purity = 90%), formic acid (purity = 98%), formaldehyde (37 wt % in water solution) 
and hydrochloric acid (37 wt% in water solution) acquired from Sigma-Aldrich. 
The salts used in this work were potassium phosphate tribasic, K3PO4, obtained 
from Acros Organics, di-potassium hydrogen phosphate tri-hydrated, K2HPO4·3H2O, 
purchased from Panreac and potassium carbonate, K2CO3 (purity > 99 wt%), acquired 
from Sigma-Aldrich. All the chemicals and materials used for HPLC-DAD as well as the 
model MA enantiomers chosen to carry out the partitioning studies are already described 
in section 2.2.2.1. 
 
Figure 17. Chemical structure of the CILs used in this section. 
 
2.3.1.2.Experimental methods 
2.3.1.2.1. Synthesis of CILs 
The synthesis of chiral ILs based on the quininium, proline and valinolium cations 
was performed as reported by Sintra et al.[125] The neutralization reaction occurred by 
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reacting the respective precursor with iodomethane, dimethyl sulfate or bromoethane. The 
characterization of the synthesized ILs is described in Appendix F. 
2.3.1.2.2. Phase diagrams and TLs 
The ternary phase diagrams of ABS composed of CIL + salts were determined 
using the cloud point titration method at 25 (±1) ºC and atmospheric pressure. The 
experimental procedure adopted has been validated in previous reports.[47,126] Summing 
up, aqueous solutions of the different salts at ≈ 35-50 (wt%) were prepared and 
repetitively added dropwise  to the CILs aqueous solutions at ≈ 6-70 (wt%) until the 
detection of a cloudy solution (biphasic region). This step was followed by the addition 
of water until the solution turns clear (monophasic region). This procedure was repeated 
alternately, under constant stirring. Each mixture composition was determined by the 
weight quantification of all components added within an uncertainty of ± 10-4 g. It should 
be stressed that the amount of water present in hydrated salts was discounted in the 
calculation of the mass fraction of the salts.  
The experimental binodal curves were correlated using Eq. 7, proposed by 
Merchuk et al.,[127] 
[𝐶𝐼𝐿] = A exp[(B[salt]0,5) − (C[salt]3)]    (Eq. 7) 
where [CIL] and [Salt] are the CIL and salt weight fractions percentages, 
respectively, and 𝐴, 𝐵 and 𝐶 are constants obtained by the regression of the experimental 
binodal data. 
The tie-lines (TLs) were determined through a well-established gravimetric 
method originally proposed by Merchuk et al.[127] and widely used by our research group 
in IL-based ABS. Two mixture points for each ABS, at the biphasic region, were prepared 
by weighing the appropriate amounts of IL + salt + water and further vigorously stirred 
and allowed to reach the thermodynamic equilibrium by the complete separation of 
phases for at least 18 h at 25 (±1) ºC. After this period, each phase was carefully separated 
and weighted within ±10-4 g. The top phase is CIL-rich and the bottom phase is salt-rich. 
Each individual TL was determined by a weight balance approach through the 
relationship between the top weight phase composition and the overall system 
composition. For the determination of TLs the following system (Eq. 8 to 11) of four 
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equations and four unknown values ([CIL]CIL, [CIL]Salt, [Salt]Salt and [Salt]CIL) was solved 
to estimate the concentration of CIL and salt in each phase), the result mandatorily 
meeting a set of premises (Eq. 12 to 14):[127]  
 
[CIL]CIL = A exp(B[salt]CIL
0.5  –  C[salt]CIL
3 )                (Eq. 8) 
[CIL]salt = A exp (B[salt]salt
0.5  –  C[salt]salt
3 )               (Eq. 9) 
[CIL]CIL =  
[CIL]M
α
− (
1−α
α
) [CIL]salt               (Eq. 10) 
[Salt]CIL =  
[salt]M
α
− (
1−α
α
) [salt]salt              (Eq. 11) 
𝑚𝐶𝐼𝐿,𝑀 =
𝑚𝐶𝐼𝐿×[𝐶𝐼𝐿]𝐶𝐼𝐿
100
+ 
𝑚𝑠𝑎𝑙𝑡×[𝐶𝐼𝐿]𝑠𝑎𝑙𝑡
100
                          (Eq.12) 
𝑚𝑠𝑎𝑙𝑡,𝑀 =
𝑚𝐶𝐼𝐿×[𝑠𝑎𝑙𝑡]𝐶𝐼𝐿
100
+  
𝑚𝑠𝑎𝑙𝑡×[𝑠𝑎𝑙𝑡]𝑠𝑎𝑙𝑡
100
               (Eq.13) 
[𝑠𝑎𝑙𝑡]𝑠𝑎𝑙𝑡−[𝑠𝑎𝑙𝑡]𝑀
[𝑠𝑎𝑙𝑡]𝑀−[𝑠𝑎𝑙𝑡]𝐶𝐼𝐿
=
𝑚𝐶𝐼𝐿
𝑚𝑠𝑎𝑙𝑡
                 (Eq.14) 
 
where the subscripts salt and CIL designate the salt-rich and CIL-rich phases, 
respectively, and M is the initial mixture composition. The parameter α is the ratio 
between the CIL-rich phase weight and the total weight of the mixture. 𝑚𝐼𝐿,𝑀, 𝑚𝑠𝑎𝑙𝑡,𝑀  
correspond to the amounts of IL and salt weighed to prepare the mixture point, whilst 𝑚𝐼𝐿 
and 𝑚𝑠𝑎𝑙𝑡 are the masses of IL-rich and salt-rich phases, respectively. For the calculation 
of the tie-line length (TLL), which is the Euclidean distance between the CIL-rich phase 
and the salt-rich phase compositions, Eq. 15 was applied.[127] 
TLL = √([salt]CIL − [salt]salt)2 + ([CIL]CIL − [CIL]salt)2   (Eq. 15) 
 
2.3.1.2.3. Partition studies of MA enantiomers in ABS composed of CILs/salts 
To evaluate the partitionof MA enantiomers between the coexisting phases in each 
type of chiral ABS tested, mixture points were selected in the biphasic region of phase 
diagrams. The extraction points selected for the cationic CIL-K3PO4 ABS are reported in 
Table 9 and appropriate amounts of each phase forming agent were added. R-MA and S-
MA aqueous solutions (0.05 g.mL-1) were added in equal amounts at a final mass fraction 
in the ABS of ca. 0.8 wt% of each enantiomer. To promote the contact between the 
enantiomers and the CIL, these were left overnight as recommended by Wu et al.[76] The 
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remaining phase forming components were then added and all mixtures were stirred 
vigorously and placed for at least 18 h at 25 (±1)ºC to reach the thermodynamic 
equilibrium between the phases, and to ensure the mandelic acid complete partitioning. 
The two phases were then separated, collected to weight measurement (within an 
uncertainty o ±10-4 g), and then filtered with syringe filters for HPLC-DAD quantification 
(section 2.2.2.2.).  
 
Table 9. Conditions studied, approximate mass fraction compositions (in percentage) and phases’ 
identification for the CIL-based partition systems investigated. 
ABS 
Top 
phase 
Bottom 
phase 
pH 
mass fraction 
composition (wt%) 
CIL Salt CIL Salt 
[C1Qui][C1SO4] 
K3PO4 
 
IL-rich Salt-rich 
≈ 13 
 
2.5 18 
[C2C2C2Pro]Br IL-rich Salt-rich 10 35 
[C1C1C1Val]I IL-rich Salt-rich 10 35 
[C1C1C1Pro]I IL-rich Salt-rich 10 35 
[C1C1C1Val] [C1SO4] IL-rich Salt-rich 10 25 
[C2C2C2Pro]Br K2CO3 IL-rich Salt-rich 20 25 
[C2C2C2Pro]Br K2HPO4 IL-rich Salt-rich ≈ 9 20 25 
 
To evaluate the extraction performance, two parameters were calculated, the 
enantiomeric excess value (e.e. %) (Eq. 16) and the extraction efficiency (EE) defined by 
Eq. 17, which gives the direct comparison between the partition behaviour of the two 
enantiomers. 
CIL/Salt-based ABS:  𝑒. 𝑒. % =
𝑚𝑅−𝑀𝐴
𝐶𝐼𝐿−𝑟𝑖𝑐ℎ−𝑚𝑆−𝑀𝐴
𝐶𝐼𝐿−𝑟𝑖𝑐ℎ
𝑚𝑅−𝑀𝐴
𝐶𝐼𝐿−𝑟𝑖𝑐ℎ+𝑚𝑆−𝑀𝐴
𝐶𝐼𝐿−𝑟𝑖𝑐ℎ100   (Eq.16) 
CIL/Salt-based ABS:  𝐸𝐸𝑀𝐴,𝐶𝐼𝐿−𝑟𝑖𝑐ℎ(%) =   
𝑚𝑅/𝑆−𝑀𝐴
𝐶𝐼𝐿−𝑟𝑖𝑐ℎ
𝑚𝑅/𝑆−𝑀𝐴
0 × 100    (Eq. 17) 
𝑚𝑅/𝑆−𝑀𝐴
𝐶𝐼𝐿−𝑟𝑖𝑐ℎ is the mass of the MA enantiomer on the CIL-rich phase and 𝑚𝑅/𝑆−𝑀𝐴
0  the 
initial mass of the MA enantiomer. 
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2.3.2. Results and discussion 
The ability of the CILs to form ABS firstly with K3PO4 and further on with other 
salts of weaker salting out power was carefully screened in order to create a versatile 
platform for enantiomeric resolution.  
The phase diagrams determination and characterization was performed as it is 
essential to develop an extraction process. The phase diagrams are shown in weight 
fraction to allow a direct screening of the mixture compositions required to obtain a 
biphasic system and in molality units for a better notion of the CILs/salt structure effect 
on the phase diagrams behaviour with no differences coming from the distinct molecular 
weights of the CILs/salts. In all CIL-based ABS the biphasic region is positioned above 
the binodal curve and the monophasic region below. Phase diagrams with the larger 
biphasic areas have CILs that are more easily salted-out by the salt.  
The detailed experimental data for the ternary phase diagrams and the 
corresponding constants (A, B and C) and standard deviations (σ) obtained considering 
Eq. 7 are presented in Appendix G (Tables G1-G9). The TLs, TLLs and the values for α 
for all the systems determined by Eq. 8-11 are presented in Table F1 in Appendix H. 
Moreover, a representative example of the graphical representation of a binodal curve, 
fitting of the experimental data by the Merchuk equation and TLs is given in Figure 18. 
 
Figure 18. Representative example of a phase diagram for the ABS composed of [C1Qui][C1SO4] + K3PO4 
+ H2O at 25 (±1)°C: binodal curve data (), TL data (), extraction point () and fitting of the 
experimental data by Merchuk equation (Eq.7). 
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2.3.2.1.Phase diagrams and partition of MA enantiomers in CIL-based ABS: 
CIL structure effect 
In a first approach, the ability of the CILs to induce the formation of ABS was 
investigated using K3PO4. According to Freire et al.,
[19] who has thoroughly reviewed IL 
+ salt ABS formation mechanisms, these are shown to be based on the 
hydrophobicity/hydrophilicity of the IL and the salting-out aptitude of the salt. K3PO4 is 
composed of a trivalent anion and is found to be a strong salting-out agent according to 
the Hofmeister series.[128] It contains a high charge density and a high hydration energy 
(ΔGhyd) which results on an enhanced phase separation aptitude as it promotes the 
partition of the water from the IL to the salt through the creation of ion-water hydration 
complexes.[129] The K3PO4 is a good option to start studying the role of CIL structure on 
the ABS formation as it will induce phase separation for a wider range of CILs. 
The ternary phase diagrams of the ABS composed of K3PO4 and CILs, namely 
[C1Qui][C1SO4], [C1C1C1Pro]I, [C2C2C2Pro]Br, [C1C1C1Val]I and [C1C1C1Val][C1SO4] 
are graphically represented in Figure 19. [C1C1C1Pro][C1SO4] did not form ABS in the 
presence of K3PO4 aqueous solution, being thus disregarded for any further study. The 
binodal curves depicted in Figure 19 allow the evaluation of the CIL structure effect on 
the K3PO4-based ABS formation.  
 
Figure 19. Phase diagrams of the ternary systems composed of CILs+ K3PO4 + H2O at 25 (±1)ºC and 
atmospheric pressure in weight percentage (A) and molality units (B): () [C1C1C1Val][C1SO4], () 
[C2C2C2Pro]Br, () [C1C1C1Val]I, () [C1Qui][C1SO4], () [C1C1C1Pro]I. 
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The ability of CILs to create ABS follows the order: [C1Qui][C1SO4] > 
[C1C1C1Val]I > [C1C1C1Val][C1SO4] > [C2C2C2Pro]Br > [C1C1C1Pro]I. [C1Qui][C1SO4] 
shows the greatest capacity to for ABS, since this is one of the most hydrophobic CILs 
considered in this set. The CILs studied allow to infer on the role of the cation in ABS 
formation ([C1Qui][C1SO4] vs. [C1C1C1Val][C1SO4] vs. [C1C1C1Pro][C1SO4]). Taking 
into account the hydrophobicity of the core structure of each cation, it is possible to 
conclude that the higher the hydrophobicity, the higher the ability to phase separation. 
The hydrophobicity in ABS studies is often derived from the solvatochromic parameters 
but since they are not available for the novel ILs here studied we can alternatively express 
them in terms of the octanol-water partition coefficients (log Kow), where compounds of 
log Kow > 0 are more hydrophobic and compounds of log Kow < 0 are more hydrophilic. 
According to the log Kow values for their core structures, the most hydrophobic compound 
is [C1Qui][C1SO4] (log Kow = 3.44 for quinine), followed by [C1C1C1Val][C1SO4] (log 
Kow = -0.08 for valinol) and [C1C1C1Pro][C1SO4] (log Kow = -0.10 for proline methyl 
ester).[123] A similar hydrophilicity of [C1C1C1Val][C1SO4] and [C1C1C1Pro][C1SO4] is 
noticed, but the later completely failed to form ABS in the presence of K3PO4. This may 
be justified by the extra degree of hydrophobicity provided by the addition of a higher 
number methyl groups to valinol than to proline methyl ester (3 vs. 2 methyl groups). The 
IL’s cation hydrophobicity-hydrophilicity role in ABS formation is well-studied in 
literature and closely agrees to the findings of this work.[19]  
The impact of the anion on the CIL-based ABS can also be studied by fixing the 
[C1C1C1Val]
+ cation for the anions [C1SO4]
- and I-. According to literature,[130] the 
influence of the IL anions upon ABS formation closely correlates with their hydrogen 
bonding accepting ability, and thus with the anions’ hydrogen-bonding basicity (β). So, 
anions with lower capacity to establish hydrogen bonds (lower β) are better candidates 
for ABS formation. Using the scale of hydrogen bond basicity of ILs proposed by Cláudio 
et al.,[131] the I- is positioned below [C1SO4]
- what is in agreement with their relative 
aptitude to form ABS. 
Having the CIL + K3PO4 ABS determined and characterized, it is important to 
assess on the CIL structure influence on the partition of MA enantiomers. Given the 
distinct extensions of the phase diagrams represented in Figure 19A, different mixture 
points at the biphasic region were selected (2.5 wt% [C1Qui][C1SO4] + 18 wt% K3PO4, 
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10 wt% [C2C2C2Pro]Br + 35 wt% K3PO4, 10 wt% [C1C1C1Val]I + 35 wt% K3PO4, 10 
wt% [C1C1C1Pro]I + 35 wt% K3PO4 and 10 wt% [C1C1C1Val][C1SO4] + 25 wt% K3PO4).  
For most CIL/salt-based ABS studied, MA displays a higher affinity for the salt-
rich phase (Figure 20). Given the alkaline nature of K3PO4
[132,133] and the pKa = 3.75 of 
MA,[123] MA is negatively charged within the range of pH, due to the deprotonation of 
one of its hydroxyl groups. Although MA has low polarity (log Kow = 0.90),
[123] its anionic 
conjugate is more polar and will partition to the salt-rich phase (more hydrophilic). Also, 
a similar phenomenon was observed for the partition of gallic acid in several IL-based 
ABS. By changing the salt and its inherent pH, the authors were able to tune the partition 
of gallic acid to opposite phases.[132] The proline-based CILs are an exception to this 
behaviour, since they induce a similar partition of MA between the two phases. This 
phenomenon can be attributed to their higher hydrophilicity. 
 
Figure 20 Extraction efficiencies (primary scale, bars, EEMA,CIL-rich) obtained for R-MA () and S-MA () 
and the enantiomeric excess (secondary scale, , e.e.MA,CILrich%) reached with the studied CIL + K3PO4 -
based ABS. 
Also, as MA is present in its anionic form, there is the possibility of some specific 
interactions being promoted between MA target enantiomers and CIL cations. Figure 20 
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displays the enantiomeric excess results of the CIL-based ABS developed. The following 
enantiomeric excess tendency was achieved for the CIL + K3PO4 systems: 
[C1Qui][C1SO4] > [C1C1C1Pro]I > [C2C2C2Pro]Br > [C1C1C1Val][C1SO4] > 
[C1C1C1Val]I. [C1Qui][C1SO4] + K3PO4 presents the highest e.e.% of -33.4 ± 1.9%, thus 
revealing the greatest aptitude to separate these enantiomers. The negative value of e.e.% 
indicates the preferential interaction of [C1Qui][C1SO4] with the S-MA enantiomer. 
Additionally, it is demonstrated that this extraction system is of simpler nature, since the 
S-MA can form a stable complexes with the CIL than the R-MA without the mediation of 
additives (such as Cu2+) as used in the work reported by Wu et al.[77] The detailed data 
obtained for the enantiomeric excess and extraction efficiencies is available in Appendix 
I. 
 
2.3.2.2. Phase diagrams and partition studies of MA enantiomers in CIL-based 
ABS: salt effect 
In order to understand the impact of the salt on the enantioseparation ability of 
CIL-based ABS, further studies were performed with salts carefully chosen from the 
Hofmeister series.[128] The use of weaker salting-out agents and the introduction of 
different ionic species in solution could be beneficial to prevent the partition of both 
enantiomers toward the CIL-rich phase due to the salt action rather than the CIL effect.[134] 
Besides K3PO4 (the strongest salting out agent of the Hofmeister series),
[135] K2HPO4 and 
K2CO3 were here tested. The most efficient CIL tested so far, [C1Qui][C1SO4], was inapt 
to form ABS with K2HPO4 and K2CO3 due to its poor water solubility. Because of its 
enhanced ability to separate both enantiomers (e.e.% = -19.5 ± 1.9%), [C2C2C2Pro]Br 
was selected for this study. 
The ternary phase diagrams of the systems composed of [C2C2C2Pro]Br and the 
three salts the are graphically represented in Figure 21 allowing the evaluation of the 
effect of the salt type on the ABS formation.  
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Figure 21. Phase diagrams of the ternary systems composed of [C2C2C2Pro]Br + Salt + H2O at 25 (±1)ºC 
and atmospheric pressure in weight percentage (A) and molality units (B): ()K2CO3, ()K3PO4 and 
()K2HPO4. 
 
The ABS formation ability follows the order K3PO4 ≈ K2HPO4 > K2CO3. This 
follows the Hofmeister series and is in good agreement with other studies where the salt 
effect was evaluated in IL-based ABS.[128,135] The salting-out of salts to form ABS can be 
related to the Gibbs free energy of hydration (ΔhydG) of the salt ions, as the salting-out 
ability seems to increase with the ΔhydG. Accordingly, the results show that CO32- (ΔhydG= 
-1315) presents a lower energy when compared to the other anions, HPO4
2- and PO4
3- 
(ΔhydG= -1789 and ΔhydG= -2765, respectively).[135]  
Having the biphasic regions well defined for these three CIL-based ABS, it was 
possible to select the mixture points to carry out the enantioseparation studies. 
The equivalent partition of MA between the two phases is similar for the three 
salts and it is in accordance with the previous results for the screened CILs-based ABS. 
For the system composed of [C2C2C2Pro]Br + K3PO4 the following values were attained: 
e.e.% of -19.5 ± 1.9% and EEMA for R-MA and S-MA of 44.1 ± 2.3 and 63.5 ± 3.6, 
respectively. This indicates the preferential interaction of [C2C2C2Pro]Br with the S-MA 
enantiomer. The enantiomeric separation results of the [C2C2C2Pro]Br + salt systems 
tested has the following enantiomeric excess tendency: [C2C2C2Pro]Br + K3PO4 > 
[C2C2C2Pro]Br + K2CO3 > [C2C2C2Pro]Br + K2HPO4. [C2C2C2Pro]Br + K3PO4 
performed with the highest e.e.% value, yet the salts with lesser salting out ability did not 
favour the enantioselective partition of the MA enantiomers.  
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Figure 22. Extraction efficiencies (primary scale, bars, EEMA,CIL-rich) obtained for R-MA () and S-MA 
() and the enantiomeric excess (secondary scale, , e.e.MA,CILrich%) reached with the studied 
[C2C2C2Pro]Br + salt -based ABS. 
2.4. Critical comparison of several chiral ABS used for MA chiral 
resolution 
The performance of the most promising ABS studied in this thesis for each type 
of system is here further compared with results from other studies. The reported 
enantiomeric excesses/enantioselectivities are depicted in Table 10. [C1Qui][C1SO4] + 
K3PO4 presents an e.e.% of -33.4 ± 1.9%, thus revealing the greatest aptitude to separate 
these enantiomers achieved in this thesis. Only two other authors reported the use of the 
chiral selector as a phase forming component in the ABS.[63,124] The quinine-based ABS 
here developed provided a higher e.e.% when compared to both other works reported, 
namely by Rocha et. al[124] with the use of anionic CILs/salt and by Tan et al.[63] with the 
use of a chiral β-CD derived polymer. Still, the systems where an extra chiral selector 
was added performed better, in general. In those works[60–62] the chiral selectors used were 
β-CD or its derivatives and these were added as an extra fourth element to the system. 
This feature bring an extra degree of complexity to the system. The highest value of 
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selectivity was attained by Xing et al.[61], where the use of surfactants was explored as 
phase formers in ABS. This system, however, had to be induced by temperature to allow 
phase split, which implies higher energetic costs. It should be stressed, however, that no 
optimization other than CIL structure and salt type was conducted. In future, conditions 
such as pH, TLLs and racemate concentrations deserve further evaluation.  
 
 
Table 10. Comparative summary of the different ABS explored in this thesis and in the literature for the 
resolution of MA enantiomers. The α values reported for the systems developed in this thesis were estimated 
as the mass ratio of enantiomers present in the chiral phase. 
System type 
ABS Phase Formers 
Chiral Selector 
Selectivity Parameters 
Refs. 
1 2 e.e.% α 
Chiral 
polymer 
Poly(MAH-β-
CD-co-
NIPAAm) 
Dextran T40 
Poly(MAH-β-
CD-co-
NIPAAm) 
n.d. 1.27 [63] 
Carbohydrate 
D-Fructose [C4mim][CF3SO4] D-Fructose 9.33 1.21 Present thesis 
PEG 2000 (NH4)2SO4 β-CD n.d. 2.46 [60] 
Triton X-114 - Cu2-β-CD 67.91 n.d. [61] 
Ethanol (NH4)2SO4 Sf-β-CD 16.3 1.69 [62] 
Amino acid L-Lysine [C4mim][CF3SO4] L-Lysine 5.76 1.11 Present thesis 
CIL 
[C1Qui][C1SO4] K3PO4 [C1Qui][C1SO4] -33.41 1.91 Present thesis 
[N4444]2[L-Glu] Na2SO4 [N4444]2[L-Glu] 12.40 1.28  
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3. Separation of enantiomers using solid-liquid biphasic 
systems 
3.1. Literature review 
Recently, a solid-liquid biphasic approach for the resolution of enantiomers was 
proposed by Song’s group.[136] This approach was aimed at resolving racemic amino acids 
using CILs aqueous solutions in a simpler and quicker way. Moreover, it allows the 
simultaneous separation and recovery of the target enantiomer, having enhanced cost-
effectiveness and simplicity.  
Using aqueous solutions composed of dicationic imidazolium-based CILs and 
cooper acetate, the authors reported L-Phe preferential precipitation. By 2D NMR and 
infrared spectroscopy, it was possible to attribute this phenomenon to the stronger 
cooperative interactions of the L-Phe with the CIL and the copper ion. In the precipitate, 
the maximum e.e.% value was of 99.2%. D-Phe remained in solution at an e.e.% value of 
67.8%. 
The same group proposed another solid-liquid system for the resolution of racemic 
phenylalanine, instead based on tropin-proline CILs.[137] The e.e.% value in the solid 
phase was 98%, with preferential interaction with the L-Phe. The resolution was 
attributed to the formation of complexes between the L-proline anion, the L-
phenylalanine and the copper ion. The possibility to recycle the CIL was also successfully 
demonstrated. The very high resolution efficiency attained for racemic phenylalanine is 
patent in both works, revealing its promising status although yet poorly explored. 
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Figure 23. Schematic representation of a chiral separation of phenylalanine enantiomers using an IL-
based solid-liquid two-phase system. Copper ion(), CIL(), L-phenylalanine (), D-phenylalanine (). 
Adapted from. [137] 
3.2. Development of anionic CILs-based SLBS 
Given the limited number of CILs and target racemic compounds reported in 
SLBS, it is of great interest to explore the ILs structural versatility and expand the type 
of target racemic compounds covered.  
In this chapter, anionic CILs were used to develop a new SLBS. The CILs were 
formed by quaternary ammonium or cholinium cations paired with amino acids as anions. 
These CILs are of low toxicity as revealed in a study[124] and economically appealing.[138] 
The precipitation studies were performed using six CILs’ aqueous solutions, where the 
impacts of the cation core, amino acid structure and chirality were investigated. 
 
3.2.1. Experimental section 
3.2.1.1.Chemicals/Materials 
The anionic ILs used in this chapter were: tetrabutylammonium L-
phenylalaninate, [N4444][L-Phe]; tetrabutylammonium D-phenylalaninate, [N4444][D-
Phe]; (2-hydroxyethyl)trimethylammonium L-phenylalaninate, [Ch][L-Phe]; (2-
hydroxyethyl)trimethylammonium D-phenylalaninate, [Ch][D-Phe]; (2-
hydroxyethyl)trimethylammonium L-alaninate, [Ch][L-Ala]; and 
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di(tetrabutylammonium) L-glutamate, [N4444]2[L-Glu]. For the synthesis of these ILs, the 
reagents used were tetrabutylammonium hydroxide, [N4444][OH] (40 wt% in water), 
choline hydroxide, [Ch][OH] (45 wt% in methanol), L-phenylalanine (purity = 99.0%) 
and D-phenylalanine (purity > 98%), which were acquired from Sigma-Aldrich, L-
glutamic acid (purity = 99%), purchased from Riedel-de-Haën, and L-alanine (purity = 
99%) acquired from Acros Organics. The CILs structures are represented in Figure 24. 
The cationic CILs tested in this chapter were: [C1Qui][C1SO4], [C1C1C1Pro]I, 
[C2C2C2Pro]Br, [C1C1C1Pro][C1SO4], [C1C1C1Val]I, [C1C1C1Val][C1SO4]. The 
chemicals used to synthesize these ILs are detailed in section 2.3.1.1.. 
The solvents used were acetonitrile and methanol, both with HPLC gradient grade, 
supplied by Fisher Chemical and CHEM-LAB, respectively.  
All the chemicals and materials for HPLC-DAD quantification, as well as the 
model MA enantiomers chosen to carry out the partitioning studies are already reported 
in section 2.2.2.1.. 
 
 
Figure 24. Name, abbreviation and chemical structures of the CILs used in this section. 
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3.2.1.2.Experimental 
3.2.1.2.1. Synthesis of CILs 
The synthesis of chiral ILs based on the quininium, proline and valinolium cations 
was performed as reported by Sintra et al. [125] The neutralization reaction occurred by 
reacting [Ch][OH] or [N4444][OH] with the respective precursor. The characterization of 
the synthesized cationic ILs is described in Appendix F and of the anionic in Appendix J. 
For the synthesis of the cholinium-based IL with L-Alanine a similar approach was 
performed with the change of the amino acid being the only difference. 
 
3.2.1.2.2. Resolution procedure 
An aqueous solution of CILs was prepared and the equimolar equivalent amount 
of each MA enantiomer was dissolved in the solution (0.154 mol.L-1). The mixture was 
stirred overnight at low speed (5 rpm) to promote the contact between the CILs and the 
MA enantiomers. After this period, for the systems where a precipitate was formed, this 
was separated from the liquid phase. The solid and liquid phases were analysed by HPLC-
DAD as previously described (see section 2.2.1.2.2.). The enantiomeric excess was 
calculated for both phases. 
CIL-based SLBS: 𝑒. 𝑒. % =
[𝑅−𝑀𝐴]𝑖𝑛 𝑠𝑜𝑙𝑖𝑑 (𝑖𝑛 𝑙𝑖𝑞𝑢𝑖𝑑)−[𝑆−𝑀𝐴]𝑖𝑛 𝑠𝑜𝑙𝑖𝑑 (𝑖𝑛 𝑙𝑖𝑞𝑢𝑖𝑑)
[𝑅−𝑀𝐴]𝑖𝑛 𝑠𝑜𝑙𝑖𝑑 (𝑖𝑛 𝑙𝑖𝑞𝑢𝑖𝑑)+[𝑆−𝑀𝐴]𝑖𝑛 𝑠𝑜𝑙𝑖𝑑 (𝑖𝑛 𝑙𝑖𝑞𝑢𝑖𝑑)
100      (Eq.18) 
 
[𝑅 − 𝑀𝐴]𝑖𝑛 𝑠𝑜𝑙𝑖𝑑 (𝑖𝑛 𝑙𝑖𝑞𝑢𝑖𝑑) is the R-enantiomer concentration present either in the 
solid or in the liquid phase. [𝑆 − 𝑀𝐴]𝑖𝑛 𝑠𝑜𝑙𝑖𝑑 (𝑖𝑛 𝑙𝑖𝑞𝑢𝑖𝑑) is the S-enantiomer concentration 
present either in the solid or in the liquid phase. The same process was performed and 
conditions maintained for the samples using L/D-phenylalanine. 
3.2.1.2.3. Characterization of the precipitates by single crystal X-ray diffraction 
Single crystal X-ray diffraction of the precipitates was done following the 
procedure described by Maximo et al.,[139] at 180 K with monochromated Mo−Kα 
radiation (λ = 0.71073 Å) on a Bruker SMART Apex II diffractometer (Bruker, Billerica, 
USA) equipped with a CCD area detector. Data reduction was carried out using a SAINT-
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NT software (Bruker, Billerica, USA), and multiscan absorption corrections were applied 
to all raw intensity data using the SADABS program (Bruker, Billerica, USA). The 
structures were solved by a combination of direct methods with subsequent difference 
Fourier syntheses and refined by full matrix least-squares on F2 using the SHELX-97.24. 
The single cell unit parameters detailed in Appendix K. 
 
3.2.2. Results and discussion 
The ability of CILs to promote the enantioselective precipitation of MA 
enantiomers was initially screened by using cationic CILs ([C1Qui][C1SO4], 
[C1C1C1Pro]I, [C2C2C2Pro]Br, [C1C1C1Pro][C1SO4], [C1C1C1Val]I, and 
[C1C1C1Val][C1SO4]) and anionic CILs ([N4444][L-Phe], [N4444][D-Phe], [Ch][L-Phe],  
[Ch][D-Phe], [Ch][L-Ala] and [N4444]2[L-Glu]). 
All cationic CILs failed to promote precipitation. Considering the anionic CILs, 
only the Phe-based ones were able to promote the enantioselective precipitation of the 
MA enantiomers. Taking these results into account, both phenylalanine enantiomers were 
also tested, individually, for their aptitude to precipitate selectively MA enantiomers. The 
data is presented in Table 11. The results indicate that L-Phe is more prone to precipitate 
S-MA, while R-MA is more easily precipitated by the D-Phe, being in accordance with 
the literature.[140,141] The same behaviour was noted for the phenylalanine-based ILs, 
independently of the cation. The IL-based systems showed higher enantioselectivities for 
the solid phase, when compared with the isolated amino acid systems. Additionally, the 
SLBS developed do not require an additive (e.g. copper anion) as previously reported in 
other works,[137,136] what further enhances even more the simplicity of this technology. 
To better understand the interactions established between the MA enantiomers 
and the CILs that induced such precipitation patterns, X-Ray diffraction analysis of the 
solids was done. Only the CILs bearing the [Ch]+ cation were able to form mono-crystals 
and thus, to be analysed by single crystal X-ray diffraction. Figure 25 corresponds to the 
results attained from the analysis of an L-Phe/S-MA crystal coming from the [Ch][L-
Phe]-based SLBS. The X-ray structure data allowed to confirm that [L-Phe] and S-MA 
were present in the solid state. Accordingly, L-Phe favourably interacts with the S-MA 
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enantiomer, explaining the precipitation results. Following the same line of thinking, D-
Phe will form more stable complexes with the R-MA enantiomer. 
 
Table 11. Enantiomeric excess values attained with the SLBS. 
ABS e.e. solid-phase% e.e. liquid-phase% 
L-Phe -35.08 30.10 
D-Phe 33.57 -28.97 
[N4444][L-Phe] -45.60 20.08 
[N4444][D-Phe] 48.96 -16.98 
[Ch][L-Phe] -38.78 22.66 
[Ch][D-Phe] 42.79 -16.23 
 
 
 
Figure 25. The structures retrieved from the X-ray diffraction data: (a) the crystal unit, a binary 
complex L-Phe+S-MA; (b) the crystal structure by stacking of crystal units. 
The results attained for the complex formed are in agreement with Guo et al. and 
can be justified by the solubility of the complexes.[142] The solubility of [L-Phe]:[S-MA] 
is lower than that of [L-Phe]:[R-MA], implicitly indicating the stronger interaction 
between the first complex.[142] Crystallographic studies of diastereomeric crystals 
performed by Okamura et al.[140] indicate that a common characteristic hydrogen-bond 
network is formed in [L-Phe]:[S-MA] crystals. The binding forces for this complex are 
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much stronger. Each unit has hydrogen bonds with translational neighboring units, 
resulting in the formation of a columnar structure which is stable and favorable from the 
viewpoint of hydrogen bonding interaction (Figure 25B). Meanwhile, [L-Phe]:[R-MA], 
is less stable, since the hydrogen bond pattern by carboxylate and ammonium was not 
found. Okamura describes six kinds of hydrogen bonds but two out of them were 
bifurcated, thus reducing the interaction force of its hydrogen bond.[140] The lattice energy 
and the interaction forces of [L-Phe]:[R-MA] are lower than those of [L-Phe]:[S-MA] 
which results in the higher solubility.  
 It can be further assumed that the cation of the IL will help promote the 
precipitation of the complex. Based on that assumption, in aqueous solution, the [MA]- 
enantiomers would compete with the [L-Phe]-, thus freeing this molecule to interact with 
[S-MA]. Simultaneously, the [Ch]+ would interact with the [R-MA], coexisting in the 
liquid phase. Figure 26 describes the possible outcome of the interactions established. 
 
Figure 26. Schematic representation of the SLBS technology and the possible outputs. 
 
Comparing the opposite capacity of [Ch][L-Phe] and [Ch][L-Ala] in creating 
SLBS, it is possible to infer about the amino acid structure importance. Particularly for 
these two amino acids, the role of the interactions established due to the presence of the 
aromatic rings can be asserted. L-Ala shows a similar structure to L-Phe, sharing the same 
chiral centre. However, the first lacks the presence of an aromatic ring. This indicates that 
the aromatic ring interaction favours the positioning of the chiral centres, promoting their 
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interaction, thus allowing enantiospecific recognition. Interaction between the positive 
electrostatic potential of one ring with the negative electrostatic potential of the neighbour 
ring should stabilise and contribute to the molecular stacking. It is then possible to infer 
that a similar reason is behind the inability of [N4444]2[L-Glu] to form a precipitate, since 
[L-Glu] also lacks the presence of an aromatic ring. Moreover, the higher amount of 
cations present, since two exist per anion, could lead to a sort of steric hindrances. 
The cationic CILs did not promote the enantioselective precipitation of MA. It is 
possible that interactions are established between the cation and the negatively charged 
enantiomer in a selective manner; however, impediments on a structural level may occur. 
Both for the valine and proline-based CILs the lack of aromatic rings must influence the 
lack of stability for a macromolecular arrangement. Quinine, has a very low solubility in 
water, and thus could facilitate the precipitation of a complex. However, it can be assumed 
that the complex structure of the molecule does not promote a stable arrangement with 
the MA enantiomer, or that the solubility of the complex is not low enough to induce 
precipitation and so, no solid complex is noted. 
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4. Conclusions 
Considering the wide range of compounds that can be used to form ABS, those of 
chiral nature were identified and used in this thesis to create a versatile enantioseparation 
platform for racemic MA (here used as model compound). Briefly, carbohydrates, amino 
acids and chiral ILs were used as chiral selectors and solvents in ABS. Since most of the 
ABS reported in literature use an additional chiral selector, these systems can be foreseen 
as simpler alternatives. 
In a first approach, a chiral separation platform based on ABS composed of 
carbohydrates and amino acids with ILs was developed in order to separate MA 
enantiomers. However, these systems did not show great aptitude for the task proposed 
with maximum enantiomeric excess values of e.e.% 9.3 ± 1.7%.  
Owing to the “designer solvent” status of ILs, these can be composed of chiral 
anions, cations or both and used for chiral separation purposes. In this ambit, ABS 
composed of cationic CILs and salts were studied. The phase diagrams were determined 
and further used to study the partition of MA enantiomers. The role of the CIL structure 
was the main influencer in both phase diagrams formation (with the hydrophobicity of 
the cation playing the major role) and enantioseparation ability. Some of these systems 
displayed good enantioselectivities, with the [C1Qui][C1SO4] + K3PO4 ABS presenting 
the best performance (e.e.% = -33.4 ± 1.9%).  
In order to fulfil the goal of creating simple techniques for racemates resolution, 
CIL-based SLBS were also developed. IL-based SLBS offer an extra degree of simplicity 
when compared to ABS, since less chemicals are used and one of the enantiomers can be 
directly isolated. This technique is recent and poorly explored in literature, but it was the 
one attaining the highest enantiosselectivities of this thesis (e.e.% of 49.0% with 
[N4444][D-Phe]), without further additives. X-Ray diffraction was additionally used to 
attempt understanding the molecular mechanisms behind the enantioseparation. The 
choice of the chiral anion structure was shown to be crucial for MA chiral resolution. 
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5. Future work 
To achieve our goal of creating a simple and highly efficient platform for the 
enantioseparation of chiral drugs, further optimization studies must be performed. 
Conditions other than the structure of the ILs, salts, amino acids and carbohydrates should 
be explored, namely pH, temperature, TLLs, racemate concentration, and racemate 
structure. Given the lack of understanding of the interactions behind the enantioseparation 
in ABS, molecular-level studies should also be conducted. NMR can be a useful technique 
as revealed in other studies of the same type.[77,136] Meanwhile, liquid-liquid 
chromatographic techniques, namely the use of centrifugal partition chromatography 
(CPC), should be investigated aiming at to develop the continuous purification of the 
racemates by the utilization of several equilibrium units. 
After reaching more significant e.e.% values, further purification steps should be 
carried. The enantiomers can be isolated from the ABS phases, for instance, by 
crystallization induced by antisolvents, pH or temperature. With the isolation of the 
enantiomers achieved, the ultimate step of this approach - the recycling and reuse of the 
phases - should be exploited. By guaranteeing a high recovery yield of the phases, there 
is an increase in the cost-effectiveness and sustainability of this technology. For the 
SLBS, operational conditions like temperature, pH, enantiomers’ concentration, should 
also be optimized aiming at increasing the enantiomeric excess as much as possible. 
Again, and following the same line of thinking for ABS, the recycling and reuse of the 
liquid phase should be considered.  
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Appendix 
A. Calibration curves for mandelic acid enantiomers  
 
Figure A1. Calibration curve of R-MA.  
 
Figure A2. Calibration curve of S-MA. 
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B. Partitioning studies of mandelic acid enantiomers for carbohydrate ABS 
 
Figure B1. Average of the experimental weight fraction compositions (wt%), enantiomeric excess (e.e. %), 
extraction efficiencies of the enantiomers (EER-MA and EES-MA) and respective standard deviations (σ) for 
the carbohydrate-based partition systems investigated. 
ABS 
100  Mass fraction 
composition / (wt%) e.e.% 
EER-MA / 
(%) 
EES-MA / 
(%) 
[QS]M [IL]M 
Carbohydrates + [C4mim][CF3SO3] + water 
D-Maltose 25.79 39.09 1.6 ± 0.0 93.1 ± 9.5 90.5 ± 9.7 
D-Sucrose 24.94 39.96 -2.0 ± 2.5 17.1 ± 5.3 17.3 ± 4.1 
D-Sorbitol 24.73 39.81 -2.4 ± 0.1 36.5 ± 2.2 37.2 ± 2.1 
D-Xylose 24.87 39.89 1.4 ± 1.7 32.7 ± 0.3 32.5 ± 0.9 
D-Glucose 24.80 39.86 -5.2 ± 1.4 14.4 ± 0.8 15.8 ± 0.7 
D-Fructose 24.85 39.73 9.3 ± 1.7 36.4 ± 0.5 29.7 ± 1.2 
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C. Partitioning studies of mandelic acid enantiomers for aminoacid-based 
ABS 
 
Table D1. Average of the experimental weight fraction compositions (wt%), enantiomeric excess (e.e. %), 
extraction efficiencies of the enantiomers (EER-MA and EES-MA) and respective standard deviations (σ) for 
the amino acid-based partition systems investigated. 
ABS 
100  Mass fraction 
composition / (wt%) e.e.% 
EER-MA / 
(%) 
EES-MA / 
(%) 
[QS]M [IL]M 
Amino acids + IL+ water 
L-Lysine + [C4mim][CF3SO3] 16.66 29.86 5.8 ± 1.9 75.1 ± 3.3 66.5 ± 4.8 
L-Lysine + [C4mim][BF4] 16.79 29.91 4.3 ± 1.2 87.7 ± 3.8 80.2 ± 0.8 
L-Lysine + [C4mim][N(CN)2] 16.05 46.52 4.4 ± 1.3 81.4 ± 4.4 75.4 ± 4.8 
L-Lysine + [P4444]Br 16.79 44.53 1.8 ± 0.1 60.9 ± 7.3 59.8 ± 7.1 
L-Proline + [C4mim][CF3SO3] 16.94 58.75 -3.6 ± 0.5 36.3 ± 3.2 37.7 ± 2.9 
L-Proline +  [P4444]Br 24.83 40.31 1.0 ± 2.6 59.9 ± 6.6 58.5 ± 5.2 
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D. Characterization of the phases  
 
Table C1. pH values of the IL/carbohydrate-based ABS phases. 
ABS pHIL-rich phase pHcarbohydrate-rich Phase 
D-Frutose + [C4mim][CF3SO3] 5.31 5.27 
D-Glucose + [C4mim][CF3SO3] 5.24 5.33 
D-Sorbitol + [C4mim][CF3SO3] 5.31 5.40 
D-Xylose + [C4mim][CF3SO3] 5.14 5.15 
D-Maltose + [C4mim][CF3SO3] 5.15 5.29 
D-Sucrose + [C4mim][CF3SO3] 5.50 5.39 
 
Table C2. pH values of the IL/amino acid-based ABS phases. 
ABS pHIL-rich phase pHamino acid-rich phase 
L-Lysine + [C4mim][CF3SO3] 10.36 10.32 
L-Lysine + [C4mim][BF4] 10.33 9.87 
L-Lysine + [P4444]Br 10.28 10.75 
L-Lysine + [C4mim][N(CN)2] 10.60 10.67 
L-Proline + [C4mim][CF3SO3] 6.29 6.45 
L-Proline + [P4444]Br 4.57 4.53 
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E. Representation of the madelic acid’s chemical structures present in 
solution at distinct pH values  
 
 
Figure E1: Mandelic acid speciation at distinct pH values. This information was adapted from the 
Chemspider database (www.chemspider.com).[123] 
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F. Characterization of chiral cationic ILs 
Three cation precursors were considered to prepare the six CILs: i) quinine, ii) L-
proline and iii) L-valine. The chemical structures and acronym of all CILs synthesized 
are depicted in Figure 17. The structure of all compounds synthesized was confirmed by 
1H and 13C NMR spectroscopy, showing a high purity level of the ionic structures after 
their synthesis. 
 
i) Quinine-based CILs 
 
 1-Methyl quininium methylsulfate, [C1Qui][C1SO4]  
 
[C1Qui][C1SO4] was obtained as a white solid (66% yield). 
1H NMR (d6-DMSO, 300 
MHz, [ppm]): δ 8.75 (d, 1H, JHH = 4.5 Hz, CNCHCH), 7.95 (d, 1H, JHH = 9.2 Hz, 
OCCHCH), 7.66 (d, 1H, JHH = 4.5 Hz, CNCHCH), 7.43 (dd, 1H, JHH = 9.2 Hz and JHH = 
2.5 Hz, OCCHCH), 7.16 (d, 1H, JHH = 2.5 Hz, OCCHC), 6.51 (d, 1H, JHH = 3.3 Hz, 
NCHCHOH), 6.18 (s, br, 1H, OH), 5.81 – 5.59 (m, 1H, CHCHCHH), 5.08 (d, 1H, JHH = 
17.3 Hz, CHCHCHH), 4.97 (d, 1H, JHH = 10.5 Hz, CHCHCHH), 4.07 (s, br, 4H, 
NCHCHOH and OCH3), 3.71 – 3.52 (m, 3H, NCH2CH and NCHHCH2), 3.39 (s, br, 4H, 
NCHCHH and CH3SO4), 3.32(s, 3H, NCH3), 2.82 – 2.70 (m, 1H, CHCHCHH), 2.17 – 
2.03 (m, 2H, NCHHCH2 and NCH2CH2CH), 2.03 – 1.96 (m, 1H, NCH2CHH), 1.94 – 
1.81 (m, 1H, , NCHCHH), 1.37 – 1.23 (m, 1H, NCH2CHH). 13C NMR (d6-DMSO, 75 
MHz, [ppm]): δ 157.90 (CHOCH3), 148.01, 144.42, 144.15, 138.56, 131.99, 125.66, 
122.14, 120.47, 117.06, 102.05, 67.30, 64.40, 64.35, 56.02 (OCH3), 54.69, 53.33 
(CH3SO4), 49.25 (NCH3), 38.11, 26.42, 25.13, 19.83. 
 
ii) L-Proline-based CILs 
 
 N,N-Dimethyl-L-proline methyl ester iodide, [C1C1C1Pro]I  
 
[C1C1C1Pro]I was obtained as a white solid (15% yield). 
1H NMR (d6-DMSO, 300 MHz, 
[ppm]): δ 4.62 (t, 1H, JHH = 10.0 Hz, CHCOOCH3), 3.74 (s, br, 4H, CHCOOCH3 and 
CHHN(CH3)2), 3.64 – 3.54 (m, 1H, CHHN(CH3)2), 3.26 (s, 3H, N(CH3)(CH3)), 3.02 (s, 
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3H, N(CH3)(CH3)), 2.43 – 2.24 (m, 2H, CH2CHCOOCH3), 2.10 – 2.00 (m, 2H, 
CH2CH2CHCOOCH3). 
13C NMR (d6-DMSO, 75 MHz, [ppm]): δ 166.71 (COOCH3), 
73.10 (CHCOOCH3), 67.51 (CH2N(CH3)2), 53.83 (COOCH3), 52.14 (N(CH3)(CH3)), 
46.77 (N(CH3)(CH3)), 24.66 (CH2CHCOOCH3), 19.14 (CH2CH2CHCOOCH3). 
 
 N,N-Dimethyl-L-proline methyl ester methylsulfate, [C1C1C1Pro][C1SO4]  
 
[C1C1C1Pro][C1SO4] was obtained as a slight yellow liquid (76% yield). 
1H NMR (d6-
DMSO, 300 MHz, [ppm]): δ 4.58 (t, 1H, JHH = 9.9 Hz, CHCOOCH3), 3.74 (s, br, 4H, 
CH3SO4 and CHHN(CH3)2), 3.61 – 3.50 (m, 1H, CHHN(CH3)2), 3.34 (s, 3H, 
CHCOOCH3), 3.25 (s, 3H, N(CH3)(CH3)), 3.01 (s, 3H, N(CH3)(CH3)), 2.42 – 2.22 (m, 
2H, CH2CHCOOCH3), 2.12 – 1.99 (m, 2H, CH2CH2CHCOOCH3). 13C NMR (d6-DMSO, 
75 MHz, [ppm]): δ 166.76 (COOCH3), 73.01 (CHCOOCH3), 67.49 (CH2N(CH3)2), 53.73 
(CH3SO4), 53.41 (COOCH3), 52.07 (N(CH3)(CH3)), 46.53 (N(CH3)(CH3)), 24.65 
(CH2CHCOOCH3), 19.08 (CH2CH2CHCOOCH3). 
 
 
 N,N-Diethyl-L-proline ethyl ester bromide, [C2C2C2Pro]Br  
 
[C2C2C2Pro]Br was obtained as a white solid (34% yield). 
1H NMR (d6-DMSO, 300 
MHz, [ppm]): δ 4.62 (t, 1H, JHH = 8.1 Hz, CHCOOCH2CH3), 4.26 – 4.12 (m, 2H, 
CHCOOCH2CH3), 3.66 – 3.29 (m, 6H, CH2N(CH2CH3)2), 2.43 – 2.18 (m, 2H, 
CH2CHCOOCH2CH3), 2.04 (p, 2H, JHH = 7.7 Hz, CH2CH2CHCOOCH2CH3), 1.32 – 1.08 
(m, 9H, COOCH2CH3 and N(CH2CH3)2). 
13C NMR (d6-DMSO, 75 MHz, [ppm]): δ 
166.79 (COOCH2CH3), 70.99 (CHCOOCH2CH3), 63.01 (CHCOOCH2CH3), 60.33 
(CH2N(CH2CH3)2), 55.01 (CH2N(CH2CH3)2), 52.19 (CH2N(CH2CH3)2), 25.65 
(CH2CHCOOCH2CH3), 19.83 (CH2CH2CHCOOCH2CH3), 14.20 (COOCH2CH3), 9.16 
(N(CH2CH3)2), 8.77 (N(CH2CH3)2). 
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iii) L-Valine-based CILs 
 
 N,N,N-Trimethyl-L-valinolium iodide, [C1C1C1Val]I  
 
[C1C1C1Val]I was obtained as a white solid (90% yield). 
1H NMR (d6-DMSO, 300 MHz, 
[ppm]): δ 5.20 (t, 1H, JHH = 4.6 Hz, OH), 3.87 – 3.70 (m, 2H, OHCH2), 3.21 – 3.16 (m, 
1H, N(CH3)3CH), 3.09 (s, 9H, N(CH3)3CH), 2.41 – 2.32 (m, 1H, (CH3)2CH), 0.97 (d, 3H, 
JHH = 7.0 Hz, (CH3)CH(CH3)), 0.90 (d, 3H, JHH = 6.7 Hz, (CH3)CH(CH3)). 
13C NMR (d6-
DMSO, 75 MHz, [ppm]): δ 79.49 (N(CH3)3CH), 55.98 (OHCH2), 52.53 (N(CH3)3), 25.95 
((CH3)2CH), 23.55 ((CH3)CH(CH3)), 18.10 ((CH3)CH(CH3)). 
 
 
 N,N,N-Trimethyl-L-valinolium methylsulfate, [C1C1C1Val][C1SO4]  
 
[C1C1C1Val][C1SO4] was obtained as a colourless liquid (88% yield). 
1H NMR (d6-
DMSO, 300 MHz, [ppm]): δ 5.25 (t, 1H, JHH = 4.5 Hz, OH), 3.87 – 3.70 (m, 2H, OHCH2), 
3.34 (s, 3H, CH3SO4), 3.18 – 3.13 (m, 1H, N(CH3)3CH), 3.07 (s, 9H, N(CH3)3CH), 2.43 
– 2.32 (m, 1H, (CH3)2CH), 0.98 (d, 3H, JHH = 7.0 Hz, (CH3)CH(CH3)), 0.92 (d, 3H, JHH 
= 6.7 Hz, (CH3)CH(CH3)). 
13C NMR (d6-DMSO, 75 MHz, [ppm]): δ 79.49 (N(CH3)3CH), 
56.01 (OHCH2), 53.42 (CH3SO4), 52.39 (N(CH3)3), 25.94 ((CH3)2CH), 23.52 
((CH3)CH(CH3)), 18.01 ((CH3)CH(CH3)). 
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G. Experimental weight fraction binodal data 
Table G1. Experimental weight fraction data for the ternary system composed of [C1Qui][C1SO4] (1) + 
K3PO4 (2) + H2O (3) at 25 (±1) °C and atmospheric pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[C1Qui][C1SO4]  
100 w1 100 w2 100 w1 100 w2 100 w1 100 w2 
3.4797 13.4833 2.2910 14.8513 1.5938 16.0788 
3.3512 12.9854 2.2601 14.6509 1.5784 15.9235 
3.2739 13.6274 2.2250 15.0564 1.5647 16.1400 
3.1658 13.1774 2.1810 14.7585 1.5457 15.9443 
3.0937 13.8071 2.1481 15.1518 1.5273 16.2407 
3.0105 13.4358 2.0941 14.7708 1.5050 16.0031 
2.9514 13.9729 2.0568 15.2343 1.4870 16.2988 
2.9110 13.7813 2.0310 15.0434 1.4623 16.0276 
2.8871 14.0025 2.0096 15.3158 1.4397 16.4101 
2.8673 13.9063 1.9867 15.1415 1.4223 16.2117 
2.8346 14.2131 1.9661 15.4075 1.4082 16.4558 
2.7687 13.8824 1.9325 15.1442 1.3956 16.3086 
2.7304 14.2545 1.9050 15.5102 1.3819 16.5486 
2.7078 14.1362 1.8740 15.2584 1.3572 16.2524 
2.6898 14.3131 1.8481 15.6119 1.3378 16.6027 
2.6548 14.1269 1.8275 15.4376 1.3112 16.2716 
2.6265 14.4116 1.8123 15.6488 1.2926 16.6195 
2.5870 14.1950 1.7939 15.4902 1.2760 16.4062 
2.5429 14.6490 1.7814 15.6662 1.2551 16.8048 
2.4953 14.3750 1.7547 15.4308 1.2304 16.474 
2.4752 14.5886 1.7281 15.8156 1.2140 16.7993 
2.4446 14.4081 1.7106 15.6555 1.1996 16.600 
2.4105 14.7759 1.6931 15.9131 1.1879 16.8357 
2.3663 14.5048 1.6597 15.5992 1.1692 16.5712 
2.3377 14.8221 1.6293 16.0608 1.1526 16.9167 
2.3094 14.6424 1.6083 15.8541 1.1425 16.7686 
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Table G1. Experimental weight fraction data for the ternary system composed of [C1Qui][C1SO4] (1) + 
K3PO4 (2) + H2O (3) at 25 (±1) °C and atmospheric pressure. (Continuation)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[C1Qui][C1SO4]  
100 w1 100 w2 100 w1 100 w2 100 w1 100 w2 
1.1316 16.9983 0.8502 17.7836 0.6673 18.3609 
1.1197 16.8192 0.8424 17.6205 0.6619 18.2126 
1.1038 17.1588 0.8353 17.8163 0.6552 18.4439 
1.0818 16.8158 0.8287 17.6750 0.6487 18.2635 
1.0628 17.2368 0.8212 17.8840 0.6417 18.5080 
1.0505 17.0378 0.8144 17.7367 0.6337 18.2759 
1.0385 17.3106 0.8071 17.9449 0.6242 18.6111 
1.0257 17.0981 0.8007 17.8020 0.6117 18.2373 
1.0153 17.3381 0.7957 17.9458 0.5991 18.7020 
1.0055 17.1701 0.7894 17.8049 0.5850 18.2615 
0.9943 17.4340 0.7810 18.0496 0.56728 18.9455 
0.9843 17.2598 0.7745 17.8983 0.5524 18.4480 
0.9773 17.4284 0.7684 18.0772 0.6673 18.3609 
0.9681 17.2648 0.7609 17.9015 0.6619 18.2126 
0.9580 17.5113 0.7511 18.1964 0.6552 18.4439 
0.9489 17.3466 0.7418 17.9701 0.6488 18.2635 
0.9395 17.5807 0.7351 18.1784 0.6417 18.5080 
0.9291 17.3854 0.7273 17.9856 0.6337 18.2759 
0.9209 17.5913 0.7233 18.1092 0.6242 18.6111 
0.9109 17.3997 0.7183 17.9815   
0.9012 17.6482 0.7136 18.1270   
0.8911 17.4509 0.7082 17.9877   
0.8824 17.6788 0.7003 18.2411   
0.8751 17.5312 0.6932 18.0556   
0.8664 17.7631 0.6841 18.3548   
0.8576 17.5837 0.6749 18.1078   
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Table G2. Experimental weight fraction data for the ternary system composed of [C1C1C1Val]I (1) + 
K3PO4 (2) + H2O (3) at 25 (±1) °C and atmospheric pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[C1C1C1Val]I 
100 w1 100 w2 100 w1 100 w2   
45.3499 4.39335 22.3253 12.3498 13.1836 16.8733 
44.146 4.27672 21.6587 11.9811 12.949 16.5730 
43.2232 5.02528 20.9142 12.9473 12.614 17.1813 
41.9877 4.88164 20.3398 12.5917 12.5166 17.0486 
40.5556 6.08241 19.5693 13.6333 12.3151 17.4196 
38.6886 5.80241 18.9911 13.2305 12.0983 17.1129 
37.6817 6.69469 18.3448 14.1445 11.7233 17.8249 
36.1497 6.42251 17.9374 13.8303 11.5626 17.5806 
34.7802 7.69781 17.3936 14.6264 11.2791 18.1325 
33.6708 7.45226 17.2026 14.4658 11.1427 17.9133 
32.3426 8.73961 16.921 14.8851 10.8803 18.4354 
31.0863 8.40015 16.4832 14.4999 10.8355 18.3595 
30.3412 9.15963 15.8953 15.4124 10.2978 19.4377 
29.7009 8.96633 15.6779 15.2017 10.0994 19.0633 
28.5662 10.1553 15.3677 15.6941 9.70651 19.8811 
27.5462 9.79265 15.073 15.3932 9.5445 19.5493 
26.8395 10.5699 14.6743 16.0464 9.16131 20.3738 
25.9945 10.2371 14.4963 15.8517 8.90356 19.8007 
25.1651 11.1895 14.2419 16.2771 8.42564 20.8896 
24.4326 10.8638 14.0823 16.0947 8.27398 20.5135 
23.5065 11.9715 13.9087 16.3905   
22.8847 11.6548 13.6386 16.0722   
 94 
 
Table G3. Experimental weight fraction data for the ternary system composed of [C1C1C1Val][C1SO4] (1) 
+ K3PO4 (2) + H2O (3) at 25 (±1) °C and atmospheric pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[C1C1C1Val][C1SO4] 
100 w1 100 w2 100 w1 100 w2 100 w1 100 w2 
38.1059 10.2622 16.617 17.9523 8.04053 23.1032 
34.6445 9.33002 16.1979 18.5109 7.92517 22.7717 
32.146 11.5496 15.8562 18.1204 7.58508 23.5156 
30.7425 11.0453 15.2351 18.9817 7.30408 22.6444 
28.5762 13.0931 14.9272 18.5981 6.62942 24.2573 
27.7231 12.7022 14.4508 19.2845 6.52229 23.8654 
27.0444 13.3731 14.1673 18.906 6.29792 24.4241 
26.5871 13.147 13.6185 19.7273 5.76499 22.3573 
25.8341 13.9106 13.4231 19.4442 4.52451 26.1765 
25.3737 13.6627 12.9314 20.201 4.0087 23.1923 
24.524 14.5483 12.7506 19.9186   
24.0026 14.239 12.2796 20.6644   
22.8656 15.4644 12.0481 20.2748   
22.6154 15.2952 11.5232 21.1388   
22.1253 15.8328 11.2749 20.6832   
21.8406 15.6291 10.8999 21.3291   
21.2134 16.3321 10.7739 21.0826   
20.8645 16.0635 10.5274 21.5178   
20.4207 16.575 10.2853 21.023   
19.8467 16.1091 9.81804 21.89   
18.9068 17.2456 9.67425 21.5694   
18.5241 16.8966 9.36529 22.1615   
17.8669 17.7202 9.2244 21.8281   
17.6844 17.5392 8.79849 22.672   
17.3904 17.9144 8.65791 22.3098   
17.1967 17.7148 8.38541 22.8699   
16.8342 18.1869 8.28297 22.5905   
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Table G4. Experimental weight fraction data for the ternary system composed of [C2C2C2Pro]Br (1) + 
K3PO4 (2) + H2O (3) at 25 (±1) °C and atmospheric pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[C2C2C2Pro]Br 
100 w1 100 w2 100 w1 100 w2 
34.5968 9.37142 10.0271 26.8925 
33.4794 9.06874 9.92852 26.6281 
32.4439 10.0263 9.49909 27.2077 
31.2633 9.66146 9.39095 26.8979 
29.428 11.4441 8.90251 27.5808 
28.4834 11.0768 8.7439 27.0894 
22.5748 17.0823 8.01405 28.1694 
22.0231 16.6648 7.88582 27.7186 
19.1217 19.7426 7.29061 28.6477 
18.7694 19.3788 7.1858 28.2359 
13.5975 25.0685 6.6904 29.0488 
13.3974 24.6996 6.5534 28.454 
12.3942 25.8474 5.80702 29.7721 
12.2367 25.5188 5.70677 29.2582 
11.8094 26.0254 5.001 30.59 
11.6787 25.7374 4.84603 29.6421 
11.2914 26.2113 3.68433 32.1318 
11.1517 25.8869 3.57364 31.1665 
10.6608 26.5094   
10.5431 26.2167   
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Table G5. Experimental weight fraction data for the ternary system composed of [C1C1C1Pro]I (1) + 
K3PO4 (2) + H2O (3) at 25 (±1) °C and atmospheric pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[C1C1C1Pro]I  
100 w1 100 w2 
67.3622 1.37789 
56.6758 1.1593 
51.5907 4.68355 
52.6796 4.78241 
51.1111 5.84407 
48.4911 5.5445 
47.0832 6.55761 
45.6124 6.35277 
44.7027 7.03258 
43.4391 6.83378 
42.6184 7.46868 
41.6253 7.29464 
39.6865 8.83839 
38.5053 8.57534 
35.8533 10.7699 
35.0428 10.5264 
8.74177 32.9767 
8.69232 32.7902 
8.00664 33.3935 
7.9628 33.2107 
7.02802 34.0592 
6.97204 33.7879 
5.17576 35.5014 
5.10948 35.0468 
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Table G6. Correlation constants obtained by the regression of the experimental binodal data from Eq. 16 
and Eq. 17 and respective standard deviations, σ, of the CIL + K3PO4 + H2O systems. 
CIL A ± σ B ± σ 105 (C ± σ) 
[C1Qui][C1SO4] 99.99 ± 0.17 -0.73 ± 0.01 29.92 ± 1.06 
[C1C1C1Val]I 103.37 ± 7.64 -0.39 ± 0.03 9.36 ± 1.17 
[C1C1C1Val][C1SO4] 76.10 ± 23.54 -0.21 ± 0.09 10.38 ± 1.53 
[C2C2C2Pro]Br 99.58  ± 2.75 -0.34 ± 0.01 2.96 ± 0.43 
[C1C1C1Pro]I 82.00 ± 8.27 -0.23 ± 0.04 2.86 ± 0.83 
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Table G7. Experimental weight fraction data for the ternary system composed of [C2C2C2Pro]Br (1) + 
K2CO3 (2) + H2O (3) at 25 (±1) °C and atmospheric pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
K2CO3 
100 w1 100 w2 100 w1 100 w2 100 w1 100 w2 
36.9434 12.1862 13.1273 27.594 6.70955 31.4919 
34.8731 11.5032 12.6237 28.453 6.56191 30.799 
31.1988 15.5578 12.4919 28.1561 6.19639 31.8678 
29.975 14.9475 12.1779 28.7049 6.04792 31.1042 
27.7851 17.5073 11.9561 28.1821 5.62995 32.4091 
27.2579 17.1751 11.3797 29.2332 5.46189 31.4416 
25.1224 19.7457 11.1743 28.7056 5.05693 32.8166 
24.0897 18.934 11.0003 29.0371 4.9242 31.9553 
20.6965 23.3079 10.9053 28.7865 4.51841 33.4411 
20.1636 22.7078 10.6422 29.298 4.38629 32.4632 
19.4176 23.717 10.4754 28.839 4.03862 33.8521 
19.1689 23.4132 10.0275 29.7432 3.9064 32.7438 
18.4365 24.4285 9.85148 29.221 3.47906 34.63 
18.2293 24.1539 9.44474 30.0784 3.37291 33.5735 
17.6694 24.9473 9.26206 29.4966 2.95859 35.5896 
17.4426 24.6271 8.92122 30.2506 2.80587 33.7525 
16.5755 25.8878 8.74131 29.6405 2.27039 36.8505 
16.3704 25.5675 8.50042 30.2012 2.21556 35.9607 
15.5675 26.7651 8.43539 29.9701   
15.4054 26.4863 8.23965 30.4346   
14.6846 27.5857 8.14304 30.0777   
14.4003 27.0517 7.81449 30.881   
13.9892 27.7063 7.61587 30.0961   
13.8719 27.474 7.21295 31.1484   
13.4195 28.2082 7.06537 30.5111   
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Table G8. Experimental weight fraction data for the ternary system composed of [C2C2C2Pro]Br (1) + 
K2HPO4 (2) + H2O (3) at 25 (±1) °C and atmospheric pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
K2HPO4 
100 w1 100 w2 
46.6524 3.19319 
44.2525 3.02893 
40.868 5.17824 
38.3658 4.8612 
35.6638 6.71133 
34.4575 6.48433 
31.4327 8.64796 
30.5346 8.40088 
28.0267 10.2678 
27.7344 10.1607 
26.7403 10.9124 
26.4561 10.7964 
24.6236 12.2049 
24.4629 12.1252 
23.4818 12.8874 
23.1973 12.7312 
20.5473 14.8332 
20.3517 14.692 
18.1942 16.4347 
18.0247 16.2817 
15.6079 18.2728 
15.4769 18.1194 
13.0958 20.1213 
13.0146 19.9965 
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Table G9. Correlation constants obtained by the regression of the experimental binodal data from Eq. 16 
and Eq. 17 and respective standard deviations, σ, of the [C2C2C2Pro]Br + Salt + H2O systems. 
Salt A ± σ B ± σ 105 (C ± σ) 
K2CO3 99.28 ± 3.20  -0.26 ± 0.01 3.59 ± 0.33 
K2HPO4 78.10 ± 5.54 -0.30 ± 0.03 5.26 ± 1.41 
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H. TLs data, the TLLs and α values 
Variable 
100x Mass fraction composition / wt% 
TLL α 
[CIL]CIL [Salt]CIL [CIL]M [Salt]M [CIL]Salt [Salt]Salt 
CIL + K3PO4 + water  
[C1Qui][C1SO4] 
29.96 2.66 2.43 17.68 0.59 18.68 33.45 0.06 
26.46 3.22 2.99 14.97 1.77 15.59 27.62 0.05 
[C1C1C1Val]I 
50.98 3.23 9.98 34.49 0.01 42.09 64.10 0.20 
52.18 3.03 20.46 19.87 0.89 30.27 58.07 0.38 
[C1C1C1Val][C1SO4] 
49.12 4.04 10.02 24.92 1.72 29.35 53.73 0.18 
51.40 3.28 20.46 19.87 1.38 30.11 56.76 0.38 
[C2C2C2Pro]Br 
38.79 7.37 9.92 34.86 0.92 43.43 52.29 0.24 
45.81 5.08 20.76 25.98 1.13 42.35 58.19 0.44 
[C1C1C1Pro]I 
31.02 14.69 10.01 35.00 1.93 42.81 40.46 0.28 
50.74 4.32 25.27 29.65 0.14 54.64 71.36 0.50 
[C2C2C2Pro]Br + Salt + water 
K2CO3 46.74 8.15 20.93 25.75 2.78 38.12 0.41 53.21 
K2HPO4 40.50 4.57 18.56 24.40 0.30 40.89 54.18 0.45 
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I. Partitioning studies of mandelic acid enantiomers for CIL-based ABS 
Table H1. Average of the experimental weight fraction compositions (wt%), enantiomeric excess (e.e. %), 
extraction efficiencies of the enantiomers (EER-MA and EES-MA) and respective standard deviations (σ) for 
all the CIL-based partition systems investigated. 
ABS 
100x Mass fraction 
composition / wt% e.e.% 
EER-MA / 
(%) 
EES-MA / 
(%) 
[CIL] [Salt] 
CIL + K3PO4 + water 
[C1Qui][C1SO4] + K3PO4 2.46 17.83 -33.4 ± 1.9 9.5 ± 2.3 18.8 ± 4.6 
[C1C1C1Val]I + K3PO4 9.85 34.22 -13.5 ± 1.8 28.2 ± 2.5 35.8 ± 1.5 
[C1C1C1Val][C1SO4] 10.04 24.79 -16.4 ± 0.5 26.1 ± 0.8 37.5 ± 1.3 
[C2C2C2Pro]Br + K3PO4 9.93 34.74 -19.5 ± 1.9 44.1 ± 2.3 63.5 ± 3.6 
[C1C1C1Pro]I + K3PO4 9.99 34.68 -24.9 ± 3.1 35.4 ± 2.4 57.9 ± 1.1 
[C2C2C2Pro]Br + Salt + water 
[C2C2C2Pro]Br + K2CO3  20.88 25.82 -16.1 ± 0.2 34.8 ± 2.4 47.5 ± 2.5 
[C2C2C2Pro]Br + K2HPO4 18.78 24.46 3.3 ± 1.7  46.5 ± 2.5 44.8 ± 0.6 
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J. Characterization of chiral anionic ILs 
 
 Tetrabutylammonium L-phenylalaninate, [N4444][L-Phe] 
 
[N4444][L-Phe] was obtained as a white solid (93% yield). 
1H NMR (D2O, 300 MHz, 
[ppm]): δ 0.95 (t, 12H, JHH = 7.3 Hz, NCH2CH2CH2CH3), 1.27 – 1.45 (sext, 8H, JHH = 
7.3 Hz, NCH2CH2CH2CH3), 1.55 – 1.72 (m, 8H, NCH2CH2CH2CH3), 2.87 (dd, 1H, JH1Hβ 
= 7.3 Hz, JHαHβ = 13.5 Hz, C6H5-CH(β)), 3.01 (dd, 1H, JH1Hα = 5.6 Hz, JHαHβ = 13.5 Hz, 
C6H5-CH(α)), 3.08 – 3.29 (m, 8H, NCH2CH2CH2CH3), 3.53 (dd, 1H, JH1Hα = 5.6 Hz, 
JH1Hβ = 7.3 Hz, O2C-CH), 7.23 – 7.45 (m, 5H, C6H5-CH2). 13C NMR (D2O, 75.47 MHz, 
[ppm]): δ 12.77, 19.09, 23.06, 40.39, 57.28, 58.03, 126.65, 128.56, 129.38, 137.99, 
181.79. 
 
 Tetrabutylammonium D-phenylalaninate, [N4444][D-Phe] 
 
[N4444][D-Phe] was obtained as a light yellow solid (97% yield). 
1H NMR (D2O, 300 
MHz, [ppm]): δ 0.95 (t, 12H, JHH = 7.3 Hz, NCH2CH2CH2CH3), 11.28 – 1.43 (sext, 8H, 
JHH = 7.3 Hz, NCH2CH2CH2CH3), 1.55 – 1.71 (m, 8H, NCH2CH2CH2CH3), 2.87 (dd, 1H, 
JH1Hβ = 7.4 Hz, JHαHβ = 13.5 Hz, C6H5-CH(β)), 3.02 (dd, 1H, JH1Hα = 5.5 Hz, JHαHβ = 13.5 
Hz, C6H5-CH(α)), 3.09 – 3.25 (m, 8H, NCH2CH2CH2CH3), 3.53 (dd, 1H, JH1Hα = 5.5 Hz, 
JH1Hβ = 7.3 Hz, O2C-CH), 7.25 – 7.43 (m, 5H, C6H5-CH2). 13C NMR (D2O, 75.47 MHz, 
[ppm]): δ 12.79, 19.09, 23.05, 40.29, 57.24, 58.02, 126.68, 128.59, 129.39, 137.91, 
181.52. 
 
 Di(tetrabutylammonium) L-glutamate, [N4444]2[L-Glu] 
 
[N4444]2[L-Glu] was obtained as a white solid (99% yield). 1H NMR (D2O, 300 
MHz, [ppm]): δ 0.95 (t, 24H, JHH = 7.3 Hz, NCH2CH2CH2CH3), 1.37 (sext, 16H, JHH = 
7.3 Hz, NCH2CH2CH2CH3), 1.56 – 1.98 (m, 18H, O2C-CH2CH2 and NCH2CH2CH2CH3), 
2.15 – 2.27 (m, 2H, O2C-CH2CH2), 3.11 – 3.33 (m, 17H, O2C-CH-NH2 and 
NCH2CH2CH2CH3). 13C NMR (D2O, 75.47 MHz, [ppm]): δ 12.77, 19.07, 23.06, 31.28, 
34.05, 55.75, 58.04, 181.71, 182.08. 
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 (2-Hydroxyethyl)trimethylammonium L-phenylalaninate, [Ch][L-Phe] 
 
[Ch][L-Phe] was obtained as a yellow liquid (90% yield). 1H NMR (D2O, 300 MHz, 
[ppm]): δ 2.85 (dd, 1H, JH1Hβ = 7.3 Hz, JHαHβ = 13.5 Hz, C6H5-CH(β)), 3.00 (dd, 1H, JH1Hα 
= 5.6 Hz, JHαHβ = 13.5 Hz, C6H5-CH(α)), 3.14 (s, 9H, N(CH3)3), 3.42 – 3.54 (m, 3H, H2N-
CH e HO-CH2CH2), 3.97 – 4.04 (m, 2H, HO-CH2CH2), 7.26 – 7.41 (m, 5H, C6H5-CH2). 
13C NMR (D2O, 75.47 MHz, [ppm]): δ 40.44, 53.76, 55.49, 57.30, 67.31, 126.66, 128.58, 
129.39, 138.05, 181.77. 
 
 (2-Hydroxyethyl)trimethylammonium D-phenylalaninate, [Ch][D-Phe] 
 
[Ch][D-Phe] was obtained as a yellow liquid (89% yield). 1H NMR (D2O, 300 MHz, 
[ppm]): δ 2.86 (dd, 1H, JH1Hβ = 7.3 Hz, JHαHβ = 13.5 Hz, C6H5-CH(β)), 3.01 (dd, 1H, JH1Hα 
= 5.6 Hz, JHαHβ = 13.6 Hz, C6H5-CH(α)), 3.15 (s, 9H, N(CH3)3), 3.43 – 3.54 (m, 3H, H2N-
CH e HO-CH2CH2), 3.98 – 4.05 (m, 2H, HO-CH2CH2), 7.25 – 7.40 (m, 5H, C6H5-CH2). 
13C NMR (D2O, 75.47 MHz, [ppm]): δ 40.44, 53.76, 55.49, 57.30, 67.37, 126.66, 128.58, 
129.39, 138.05, 181.77. 
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K. Crystal data 
 
Table K1: Single cell unit parameters. 
A 19.25750 Å 
B 5.71920 Å 
C 15.61720 Å 
α 90.00000° 
β 115.41400° 
γ 90.00000° 
 
 
 
 
 
 
